Drug Treatment Centre Board pioneers nurse prescribing in addiction in Ireland. by Lyons, Suzi
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Mr John Curran TD, Minister of State with responsibility for the National Drugs Strategy, 
opened a national conference on ‘legal highs’ organised by the regional drugs task forces on 
26 January in Mullingar. Minister Curran said that he had expressed concerns about the sale 
of legal highs and their possible health hazards on numerous occasions in the last year. He has 
asked the Minister for Health and Children, who has responsibility in relation to the importation, 
exportation, production, supply and possession of a range of named narcotic drugs and 
psychotropic substances under the Misuse of Drugs Acts, ‘to ensure that every effort is made to 
expedite the response to this issue through the early control of substances under that Act’. He 
has also asked the Department of Enterprise, Trade and Employment to examine issues relating 
to insurance and consumer protection. 
Dr Jean Long of the Health Research Board presented a review of the availability of 
psychoactive drugs in head shops and on line across Europe. She said that more than 90 new 
psychoactive substances had been reported through the EMCDDA’s early-warning system since 
its establishment in 1997. Until recently, phenethylamines and tryptamines accounted for a 
large proportion of notifi cations to the EMCDDA. However, since 2004, a much more diverse 
range of substances has become available; among these are numerous piperazine compounds, 
cathinone derivatives and Spice products, as well as a heterogeneous mix of other substances. 
Dr Long reported that all countries in the EU had controlled the use of BZP, that eight countries 
had introduced controls on the use of synthetic cannabinoids (found in Spice), and that many 
countries were at present examining the issues pertaining to cathinone derivatives. She noted 
that there were reports that drug users were injecting some of the cathinone derivatives, which 
can lead to local infections, blood-borne viral infections and deep venous thrombosis. One of 
the cathinone derivatives was implicated in two deaths in Sweden. 
Laboratories across Europe reported that the ingredients listed on the packaging of head shop 
products did not always match the ingredients found on forensic analysis, and that it was 
diffi cult to advise people about the use of such drugs when their exact chemical contents were 
not known. Some of the products contained synthetic rather than herbal substances. 
Dr Bobby Smyth, consultant child and adolescent psychiatrist, presented some of the known 
and probable health-related harms associated with psychoactive drugs sold in head shops. He 
said that 7% of young people attending adolescent addiction services in the south west of 
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Conference on psychoactive drugs sold in head shops 
and on line (continued)
Dublin were using head-shop drugs as part of 
a polydrug cocktail. Dr Smyth reported that 
these drugs may become another gateway 
drug, alongside alcohol and tobacco. He 
presented eight cases of individuals who had 
experienced adverse effects of head shop 
products, such as anxiety, excessive aggression, 
paranoia, psychosis and hallucinations. A small 
number of these individuals had a previous 
history of mental illness. He said that it is likely 
that these drugs exacerbate mental illness and 
that they were likely to negatively affect brain 
development in adolescents. He made the point 
that there were no quality control measures 
on the production, distribution or sale of these 
substances, and that, in the instances of adverse 
reactions, no one was accountable. 
Mr Noel O’Connor of Merchants Quay Ireland 
spoke of the diffi culty in developing harm-
reduction strategies to deal with legal highs 
because the contents of each drug were 
not known or guaranteed. The substances 
were not rigorously tested in a controlled 
environment prior to selling them to the 
public. The ingredients were unfamiliar to the 
general population and it was diffi cult to fi nd 
information on the products. 
Dr Des Corrigan, chairman of the National 
Advisory Committee on Drugs, presented an 
overview of the products available in head 
shops, their ingredients and their effects. He 
said that it was common for head shops to use 
the Latin name of plants and chemicals in their 
list of ingredients. He said that a number of 
plants were used as stimulants and that there 
were many strong caffeine-based products on 
the market. In addition, he noted that many 
head-shop drugs contained piperine, the main 
chemical in black pepper, which increases the 
ability of the body to absorb the drugs. 
Dr Corrigan’s description of the main 
psychoactive drugs sold in head shops in Ireland 
is summarised below:
Ephedrine ■ , which is chemically similar to 
amphetamine, is available in head shops 
in the form of Sida cordifolia, which is not 
controlled in Ireland. Two other forms of 
the drug, Ma Hung and synthetic ephedrine, 
are available in Ireland only on medical 
prescription dispensed by a pharmacist. The 
producers of one product containing Sida 
cordifolia state on the packaging that they 
take no responsibility for any consequences 
associated with its use. Chemically similar 
to amphetamine, ephedrine can induce 
dependence, psychosis, high blood pressure 
and increased heart rate.
Morning glory  ■ (Ipomoea) and Hawaiian 
baby woodrose (Argyreia nervosa) are 
listed as ingredients in a number of head-
shop products that may be labelled ‘not for 
human consumption’. Both plants contain 
LSA (lysergic acid amide), a relative of LSD. 
The side effects of LSA and related chemicals 
include: apathy, tiredness, decreased 
psychomotor activity and feelings of 
unreality. As a form of lysergamide, LSA is 
controlled under the Misuse of Drugs Act.
Salvia divinorum ■  (divine mint) contains 
chemicals called salvinorins that have a 
potency similar to that of LSD. Its use can 
lead to euphoria, feelings of levitation, 
out-of-body experience and, at high doses, 
uncontrolled delirium. The duration of its 
effects is short and the come-down is quick 
and therefore severe. It can induce mental 
health symptoms such as paranoia and 
derealisation. 
Three types of  ■ hallucinogenic cacti 
containing mescaline are sold in head shops. 
Their common names are peyote, San Pedro 
and Peruvian torch. Mescaline from peyote 
induces hallucinations as well as nausea and 
vomiting. 
Kratom ■ , which contains mitragynine (an 
opioid agonist), is a leaf chewed in south-
east Asia as a stimulant at low doses and as a 
painkiller or sedative at higher doses. It can 
cause constipation, weight loss, dependence, 
psychosis and withdrawal symptoms. It is 
not controlled in Ireland.
Piperazines ■  such as 1-benzylpiperazine 
(BZP), methylbenzylpiperazine, meta 
chlorophenyl-piperazine (mCPP) and 
1-(4-fl uorophenyl) piperazine are synthetic 
drugs with psychedelic and euphoric effects 
which mirror those of ecstasy. They are sold 
as an ingredient in recreational drugs known 
as ‘party pills’. BZP was banned in Europe in 
March 2008 and in Ireland in March 2009. 
Other forms of piperazine are not controlled 
in Ireland. BZP can lead to hyperthermia, 
high blood pressure, fast pulse, and 
convulsions. 
Spice products ■  are largely a mix of 
innocuous herbs, but six synthetic 
cannabinoids have been detected in the 
various spice products sold across Europe. 
Synthetic cannabinoids are more potent 
than the main psychoactive compound 
(THC) in natural cannabis, and do not 
contain the anti-psychotic substances found 
in natural cannabis. They may therefore lead 
to a higher incidence of psychosis associated 
with cannabinoid use. There is also potential 
for dependence. These products have been 
banned in eight countries across Europe. 
Cathinone ■  is a naturally occurring stimulant 
found in the khat plant, and cathinones are 
a group of drugs related to amphetamine 
compounds. Methcathinone, methylmeth-
cathinone (mephedrone) and methedrone, 
derivatives of cathinone, are sold as ‘legal 
drugnet 
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Europe under a variety of names, such as MCAT, Snow, 
Charge. Some of these products are sold as bath salts 
or plant food. The contents listed on the package may 
contain the word ‘ketones’. These compounds are 
advertised as a replacement for ‘Charlie’ (cocaine). Some 
users have reported injecting the compounds. The use 
of these drugs can induce anxiety and paranoia. Reports 
say that their use can become compulsive and can create 
a state of psychological dependence. Mephedrone was 
linked to two deaths in Sweden in 2008. 
(Jean Long)
Podcasts of the presentations given at the conference are 
available at www.drugs.ie/media
Department of Health and Children statement in 
relation to legislation to be made under Misuse of 
Drugs Act 1977
The Government agreed at its meeting on 2 March 2010 
to the commencement of a notifi cation process under 
Directive 98/34/EC (the 'Technical Standards' Directive) 
as amended by Directive 98/48/EC, of the Government’s 
intention to make a Declaration Order under the Misuse of 
Drugs Act 1977 declaring certain substances, products and 
preparations to be controlled drugs for the purposes of the 
Misuse of Drugs Acts 1977 and 1984. 
The substances concerned include a range of products sold 
in so-called ‘head shops’ including:
synthetic cannabinoids (for example, Spice products)  ■
benzylpiperazine (BZP) derivatives  ■
mephedrone, methylone and related cathinones  ■
GBL and 1,4 BD  ■
In addition, the Declaration Order to be made under 
the Misuse of Drugs Act 1977 will include Ketamine and 
Tapentadol which are substances that have legitimate 
uses as medicines but which can be subject to misuse. 
The Declaration Order will also cover certain narcotic 
and psychotropic substances which Ireland is obliged 
to bring under control in order to comply with the 
UN Single Convention on Narcotic Drugs and the UN 
Convention on Psychotropic Substances. 
www.dohc.ie/press/releases/2010/20100303.html
Legal highs and head shops: the basic facts
In response to interest among drug workers 
regarding ‘legal high’ drugs available in head 
shops, Ballyfermot Advance Project and The 
Base youth and child centre in Ballyfermot have 
produced an information leafl et. 
The leafl et outlines the current legal status and 
effects of common drugs such as Salvia, Spice, 
Piperazine, BZP and Kratom. There is also harm 
reduction information that may be used to advise 
clients of risks. 
Content has been approved by Dr Des Corrigan, 
chairperson of the NACD, and Dr Bobby Smyth, 
consultant child and adolescent psychiatrist.
This brief, timely and straight-forward resource 
is available to download from 
www.drugsandalcohol.ie/12941
For more information, or for hard copies, please 
email community@ballyfermotadvance.ie.
Conference on psychoactive drugs sold in head shops and on line (continued)
Alcohol and drug use among young people 
in Ireland
There are three sources of data that estimate the prevalence 
of alcohol and other drug use among young people in 
Ireland: the National Advisory Committee on Drugs (NACD) 
surveys on drug use among the general population,1,2 the 
European School Survey Project on Alcohol and Other Drugs 
(known as the ESPAD surveys)3,4,5 and the Health Behaviour 
in School-aged Children (HBSC) surveys.6,7,8 The NACD 
surveys classify young adults as those aged between 15 and 
34, while the ESPAD surveys ascertain alcohol- and drug-
using practices among 15–16-year-old school children. The 
HBSC surveys record health behaviours (including cannabis 
use) among school children aged 13–17 years. Drug use was 
measured for three time parameters, lifetime use, use in the 
12 months prior to the survey and use in the month prior 
to the survey. 
Drug use 
According to the NACD general population surveys, the 
proportion of young adults who reported using an illegal 
drug in the year prior to the survey increased from 10% 
in 2002/3 to 12% in 2006/7 (Figure 1). The proportions 
using cannabis showed a similar increase, rising by almost 
two percentage points, to over 10%. The proportions using 
cocaine increased for all three time parameters and the 
proportions using ecstasy during their lifetime or in the 12 
months prior to the survey increased marginally.
drugnet 
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the trends in lifetime use reported above.
Figure 3 Use of drugs in the 12 months prior to the survey among 15–16-year-old school children in Ireland, ESPAD 
1999, 2003 and 2007 
 Source: ESPAD (2000, 2004, 2009)
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Figure 1 Lifetime, last-year and last-month prevalence of illegal drug use among 15–34-year-olds in Ireland, 
2002/3 and 2006/7
 Source: National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit (2005, 2008)
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In the ESPAD surveys, the proportion of 15–16-year-old 
school children who reported use of any illicit drug at some 
point in their life decreased markedly between 2003 (40%) 
and 2007 (22%), a fall of 18 percentage points (Figure 
2). As the majority of those who have tried any illicit drug 
have used cannabis (marijuana or hashish), the decrease in 
illicit drug use was infl uenced by the considerable decrease 
in the percentage of students who had tried cannabis at 
some point in their lives, from 39% in 2003 to 20% in 
2007 (European average 19%). Lifetime use of solvents/
inhalants decreased from 18% in 2003 to 15% in 2007, but 
remained higher than the European average (9%). In the 
case of amphetamines and cocaine powder, the proportions 
reporting lifetime use increased marginally to equal or 
exceed the European average of 3%. In 2007, one in ten 
of the survey participants reported that they had taken 
prescribed tranquillisers or sedatives at some point in 
their lives; the use of such drugs had decreased marginally 
since 1999. 
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Figure 2 Lifetime use of drugs among 15–16-year-old school children in Ireland, ESPAD 1999, 2003 and 2007 
 Source: ESPAD (2000, 2004, 2009)
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use at some point in their life increased with each year of 
age between 13 and 17 in all three HBSC surveys, except 
for 17-year-olds in 1998 (Figure 4). In 2006, 6% of 13-year-
olds reported lifetime use of cannabis, and the proportion 
increased steadily with each year of age, to 38% for those 
aged 17 years. The proportions of those who had used 
cannabis in each age group from 14 to 17 years increased 
between 1998 and 2006. 
Figure 4 Proportion of children who used cannabis 
at least once in their life, by age, HBSC 
1998 2002 and 2006
 Source: Unpublished data from HBSC surveys
The proportion of children who reported commencing 
cannabis use at 13 years or under was considerable, and 
similar in both the HBSC and ESPAD surveys (Figure 5). 
In 2006/7, the proportion who had used cannabis three or 
more times was higher in the HBSC (10.4% and 12.3%) 
than in the ESPAD survey (8%) (Figure 6). 
Figure 5 Age commenced cannabis use for children 
aged 15–16 years, HBSC 2006 and ESPAD 2007
 Source: Unpublished data from HBSC survey 
2006 and published data from ESPAD (2009)
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Alcohol and drug use among young people in Ireland (continued) 
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Figure 6 Frequency of cannabis use in the 12 months prior to the survey among 15–16-year-olds, HBSC 2006 
and ESPAD 2007
 Source: Unpublished data from HBSC survey 2006 and published data from ESPAD (2009)
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The HBSC and ESPAD surveys also examined alcohol use 
among schoolchildren. According to the last three HBSC 
surveys, the majority of schoolchildren had consumed 
alcohol, although the rate of lifetime use among the age 
groups from 13 to 16 years was lower in 2006 than in 
1998. The largest decrease was observed among 13-year-
olds; in 1998 66% reported having ever consumed alcohol, 
compared to 43% in 2006. The likelihood of having ever 
consumed alcohol increased with each year of age, with 
almost nine in ten 17-year-olds having ever consumed 
alcohol (Figure 7). 
Figure 7 Lifetime use of alcohol among 13–17-year-
old schoolchildren, HBSC 1998, 2002, 2006
 Source: Unpublished data from HBSC surveys
Last-month use of alcohol decreased among the age groups 
from 13 to 16 years between 1998 and 2006. In all three 
surveys, rates of alcohol use were higher at each year of age; 
for example, in 2006, 13% of 13-year-olds, and 25% of 
14-year-olds had consumed alcohol in the previous month, 
(Figure 8).
Figure 8 Last-month use of alcohol among 
13–17-year-old school children, HBSC 
1998, 2002, 2006 
 Source: Unpublished data from HBSC surveys
According to the 2007 ESPAD survey, over half of 
15–16-year-olds reported having ever been drunk (Figure 9). 
The percentages reporting drunkenness did not vary to any 
great extent across the three HBSC surveys. However, there 
were variations between the ESPAD and the HBSC surveys: 
in the 1999 and 2003 ESPAD surveys, the proportion of 
15–16-year-olds who reported having ever been drunk was 
considerably higher than in the HBSC surveys. The 2007 
ESPAD results were similar to those of the 2006 HBSC survey.
Figure 9 Proportion of 15–16-year-olds who 
reported having ever been drunk, HBSC 
1998, 2002, 2006; ESPAD 1999, 2003, 2007 
 Source: Unpublished data from HBSC surveys; 
Data from ESPAD (2000, 2004, 2009)
The proportion of 15-year-olds who reported having been 
drunk at least 10 times remained relatively stable over the 
three HBSC surveys, while the proportion of 16-year-olds 
decreased marginally (Figure 10). The ESPAD surveys of 
1999 and 2003 reported 37% and 41%, respectively, of 
15- and 16-year-olds who had been drunk at least 10 times. 
In comparison, just 17% reported the same in 2007. The 
results of the ESPAD and HBSC surveys were closer in 2007 
than in previous years.
Figure 10 Proportion of 15–16-year-olds who 
reported having been drunk at least 10 
times (HBSC 1998, 2002, 2006; ESPAD 1999, 
2003, 2007) 
 Source: Unpublished data from HBSC surveys; 
Data from ESPAD (2000, 2004, 2009)
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Alcohol and drug use among young people in Ireland (continued) 
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Overall, the HBSC surveys show a steady increase in 
cannabis use between 1998 and 2006, whereas the ESPAD 
surveys show a large increase between 1999 and 2003 and 
a larger, unexpected, decrease between 2003 and 2007. 
The HBSC survey results are in line with those of the NACD 
survey and other epidemiological indicators. They show a 
steady decrease in lifetime and last-month use of alcohol 
among 13–16-year-olds, but do not report major changes in 
drunkenness. In comparison, the 2007 ESPAD survey shows 
a large decrease in drunkenness compared to the 1999 and 
2003 fi gures. 
It is important to investigate the reasons for the marked 
decrease in alcohol use and in cannabis use reported in 
the ESPAD survey of 2007; these fi gures could represent a 
genuine fall in the use of alcohol and cannabis, or a change 
in the profi le (age, gender or socio-economic group) of 
the sample chosen, or in the way the questionnaire was 
administered. 
(Jean Long and Deirdre Mongan)
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Alcohol and drug use among young people in Ireland (continued) 
Alcohol use in Ireland: results from 
SLÁN 2007
On 1 December 2009, the SLÁN (Survey of Lifestyle, 
Attitudes and Nutrition) group published the results of the 
alcohol component of the 2007 SLÁN survey.1 This was the 
third SLÁN survey – previous surveys were conducted in 
1998 and 2002. The survey involved 10,364 adults aged 
18 years and over, representing a response rate of 62%. 
As part of the survey, participants were questioned in face-
to-face interviews about their rates and patterns of alcohol 
consumption, harm from their own drinking and harm from 
others’ drinking.
Alcohol consumption and drinking patterns in Ireland
Four-fi fths (81%) reported that they had consumed alcohol 
in the past year, with women (23%) more likely than 
men (15%) to be abstainers from alcohol. Higher rates of 
abstinence were reported by older respondents than by 
younger ones: for example, 41% of those aged 65 and over 
abstained from alcohol, compared to 11% of 18–29-year-
olds. Three-quarters of the total number of respondents 
reported that they had consumed alcohol in the previous 
week, and 38% (45% of men; 30% of women) consumed 
alcohol at least twice a week. Twenty-nine per cent of 
drinkers reported consuming 1–2 standard drinks on a 
typical drinking occasion. A standard drink was defi ned as a 
half pint or a glass of beer, lager or cider; a single measure 
of spirits; a single glass of wine; or a longneck bottle of 
alcopops. Two-fi fths (41%) reported drinking at least fi ve 
standard drinks on a typical drinking occasion. This was 
more common among men (54%) than women (27%) and 
among younger age groups. 
One in 10 drinkers reported drinking over the recommended 
weekly alcohol limit (defi ned as 21 standard drinks for men 
and 14 standard drinks for women) and 28% engaged in 
weekly binge drinking (defi ned as consuming at least six 
standard drinks or 60g of alcohol on a single occasion). 
Drinking patterns were also assessed using the Alcohol 
Use Disorders Identifi cation Test – Consumption (AUDIT-C), 
which identifi es those with harmful drinking patterns by 
examining frequency of drinking, volume consumed and 
extent of binge drinking. Over half (56%) of drinkers had a 
positive AUDIT-C score. Applying this percentage to 
drugnet 
IRELAND
8Alcohol use in Ireland: results from SLÁN 2007 (continued) 
the 2006 population census fi gures,, one may extrapolate 
that 1,453,250 people in Ireland aged 18 or over have a 
positive AUDIT-C score. Male and younger drinkers were 
more likely to drink over the recommended weekly limit, 
to be weekly binge drinkers and to have a positive 
AUDIT-C score.
Table 1 Selected drinking patterns by gender and age group 
Abstainer Drinking at 
least twice 
weekly
Drinking in 
past week
5+ drinks 
per drinking 
occasion
Weekly binge 
drinking
Positive 
AUDIT-C score
All respondents Drinkers
% % % % % %
Total 19 38 75 41 28 56
Gender
Men 15 45 80 54 38 70
Women 23 30 70 27 17 42
Age group
18–29 11 38 77 67 40 74
30–44 14 38 74 40 27 57
45–64 21 41 76 29 23 48
65+ 41 28 73 16 12 28
Harm related to respondents’ own drinking
One in 10 drinkers reported that their drinking had harmed 
their health in the previous year. Younger drinkers were 
more likely to report health harms; the percentages were: 
17% of those aged 18–29; 10% of those aged 30–44; 7% of 
those aged 45–64; and 2% of those aged 65+. Drinkers who 
exceeded the recommended weekly limit were four times 
more likely to report that their drinking had harmed their 
health, while binge drinkers were three times more likely to 
report similar harm. 
Harm to home life and/or marriage as a result of their own 
drinking was reported by 4% of men and 2% of women, 
while 6% of men and 3% of women reported that their 
drinking had harmed their work or studies in the previous 
year. Involvement in fi ghts and/or accidents as a result of 
their own drinking was reported by 5% of drinkers (7% of 
men; 3% of women). Binge drinkers were almost fi ve times 
more likely than non-binge drinkers to be involved in a fi ght 
or accident as a result of their own drinking.
Twelve per cent of drivers who were also drinkers reported 
driving a car in the previous year after consuming two or 
more standard drinks and this was reported more often by 
men (17%) than by women (5%). Self-reported rates of 
driving after consuming two or more standard drinks were 
similar across all age groups. 
Harm related to other people’s drinking
Drinkers experienced more harm from others’ drinking 
than did non-drinkers. Six per cent of all respondents 
(5% of men; 7% of women) reported experiencing family 
or marriage problems in the previous year as a result of 
someone else’s drinking. Six per cent reported being pushed, 
hit or assaulted as a result of someone else’s drinking, with a 
higher rate (13%) reported by younger respondents. Binge 
drinkers were twice as likely to report being assaulted as all 
other respondents.
Conclusion
This report indicates that rates of alcohol consumption 
in Ireland are high and that our drinking patterns are 
problematic. Over one in four drinkers reported binge 
drinking weekly, and over half of drinkers scored positive 
on the AUDIT-C questionnaire, indicating that a large 
proportion of drinkers consume alcohol in a hazardous 
manner. This is worrying as the volume of consumption as 
well as patterns of drinking, especially regular heavy drinking, 
determine the burden of disease caused by alcohol. Binge 
drinking, apart from any long-term effects, can increase 
impulsivity, reduce inhibition and distort behaviour, which 
may lead to acute consequences such as accidents, assaults 
or suicide. There is a pressing need to introduce strategies 
that will reduce the harmful use of alcohol in Ireland and, by 
extension, the health and social harms 
it causes.
(Deirdre Mongan)
Morgan K, McGee H, Dicker P, Brugha R, Ward M, 1. 
Shelley E et al. (2009) SLÁN 2007: Survey of lifestyle, 
attitudes and nutrition in Ireland. Alcohol use in Ireland: a 
profi le of drinking patterns and alcohol-related harm from 
SLÁN 2007. Dublin: Department of Health and Children.
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alcoholism among 9-year-old 
Irish children
On 7 December 2009 the Minister for Children and Youth 
Affairs, Barry Andrews TD, launched the fi rst major report 
from Growing Up in Ireland, the national longitudinal study 
of children, tracking the lives of over 8,500 nine-year-olds. 
The data were collected between September 2007 and June 
2008.1 The nine-year-old cohort was selected through the 
primary school network. 
A random sample of schools was drawn and, subject to the 
school’s participation, age-eligible children in those schools 
and their families were invited to participate. The study 
included a wide range of perspectives, with information 
being recorded from parents, teachers, principals and 
carers, and the ‘study child’ himself or herself. Aspects 
explored included the children’s living situations; 
experiences of family life; state of health; use of health 
care services; emotional health and wellbeing; education; 
peer relationships; activities; and neighbourhood and 
community settings. 
With regard to the children’s experiences of stressful life, 
their mothers were presented with a list of 13 potentially 
stressful events and asked to report which ones, if any, 
their child had experienced. Just over 78% of children 
were reported to have experienced some form of stressful 
life event; 4% had experienced drug taking/alcoholism in 
their immediate family. As the following table shows, in 
comparison with children from two-parent families, 
children from single-parent families were more likely to 
have experienced drug taking/alcoholism in their 
immediate family.
Family unit Percentage of 9-year-olds 
experiencing drug-taking/
alcoholism in their 
immediate family
Single-parent – 1 or 2 
children
10.0
Single-parent – 3 or more 
children
10.7
Two-parent – 1 or 2 
children
2.0
Two-parent – 3 or more 
children
2.0
With regard to the quality of their neighbourhood 
environments, the mothers were asked to rate four items 
on a four-point scale from very common to not at all common. 
Overall, rubbish and litter lying about appeared to be the 
most pervasive problem, with mothers of 34% of nine-year-
olds reporting this as being very common or fairly common in 
their local area. 
This was followed by people being drunk or taking drugs 
in public (15%), vandalism and deliberate damage to 
property (15%) and homes and gardens in bad condition 
(10%). There was a strong relationship between family 
social class and perceived quality of the local area, with 
those in the lower social class categories being much more 
likely to report unfavourable physical conditions in their 
neighbourhood. For example, those in the semi-skilled/
unskilled manual category were more likely than those in the 
professional/managerial group to report that people being 
drunk or taking drugs in public was very common or fairly 
common (22% compared to 9%). The researchers also found 
a difference between urban and rural residents in terms 
of the quality of the neighbourhood environment, with 
respondents in urban areas being roughly twice as likely as 
their rural counterparts to report that people being drunk or 
taking drugs in public was very or fairly common.
The next wave of this longitudinal study is due to be 
conducted when the children in the cohort study reach the 
age of 13. 
(Brigid Pike)
Williams J, Greene S, Doyle E, Harris E, Layte R, McCoy S 1. 
et al. (2009) Growing up in Ireland: national longitudinal 
study. The lives of 9-year-olds, child cohort. Report 1. 
Dublin: Stationery Offi ce. 
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On 7 October 2009 the National Economic and Social 
Council (NESC) launched a report Well-being matters: a 
social report for Ireland.1 Speaking at the launch 
NESC director Dr Rory O’Donnell called for a broader 
understanding of social progress than simply measuring GDP. 
The report tracks trends across six aspects of people’s lives: 
their economic resources, their work and education, their 
relationships and care, their community and environment, 
their health, and societal values. Alcohol consumption is 
included as an indicator of health, together with four other 
behavioural components – smoking, physical exercise, 
eating and weight. 
Indicators of health: behavioural components 
Indicator Finding 
Smoking cigarettes has a 
detrimental effect on health 
and well-being.
Just under a third of the 
population smoke, with 
a slight reduction having 
taken place over the last 
nine years.
Excessive alcohol 
consumption has a 
detrimental effect on health 
and well-being.
Ireland is one of the highest 
consumers of alcohol in 
Europe, with high rates of 
heavy drinking compared 
to EU averages.
Physical exercise and good 
diet have positive effects on 
health and well-being.
Levels of physical activity 
have increased signifi cantly 
over the last twenty years. 
In relation to diet, even 
though two-thirds of 
people are eating the 
recommended amounts 
of fruit and vegetables, 
many people (86%) are 
consuming more than the 
recommended servings of 
fat, sugar and salt.
Being overweight or obese 
can contribute to health 
problems.
Between one-half to two-
thirds of the population can 
be classifi ed as overweight 
or obese, and the 
proportion is increasing.
Source: Johnston (2009:115)
The report’s author, Helen Johnston, notes that health 
behaviours are infl uenced by a wide range of socio-
economic and cultural factors. Some sub-groups of the 
population are more at risk of poor health than others and 
have less access to treatments and services. These sub-
groups include people with lower educational levels or 
lower incomes, or who are unskilled. In addition, Johnston 
cites a recent study2 which ‘shows that “inequality seems 
to make countries socially dysfunctional across a wide 
range of outcomes” in that “rich” countries with a highly 
unequal income distribution are more likely to have lower 
levels of trust, higher levels of mental illness (including drug 
and alcohol addiction), lower life expectancy and higher 
infant mortality, higher levels of obesity, poorer educational 
performance, more teenage births, more homicides, higher 
imprisonment rates and more limited social mobility’ 
(Johnston 2009: 76). 
(Brigid Pike)
Johnston, H (2009) 1. Well-being matters: a social report 
for Ireland. Report No 119. Volume 1. Dublin: National 
Economic and Social Council.
Wilkinson R and Pickett K (2009) 2. The spirit level: why 
more equal societies almost always do better. London: 
Allen Lane.
What is well-being?
A person’s well-being relates to their physical, social and 
mental state. It requires that basic needs are met, that 
people have a sense of purpose, that they feel able to 
achieve important goals, to participate in society and to 
live the lives they value and have reason to value. People’s 
well-being is enhanced by conditions that include fi nancial 
and personal security, meaningful and rewarding work, 
supportive personal relationships, strong and inclusive 
communities, good health, a healthy and attractive 
environment, and values of democracy and social justice. 
Public policy’s role is to bring about these conditions by 
placing the individual at the centre of policy development 
and delivery, by assessing the risks facing him/her, and 
ensuring the supports are available to address those risks 
at key stages in his/her life. 
Source: Johnston (2009: xiii)
Levels of alcohol and drug use are 
indicators of wellbeing
 
Launch of D12 LDTF 
Managers Support Book
Minister Curran at the launch on 9 March 2010 of the 
Dublin 12 LDTF Managers Support Book, pictured 
with Dublin 12 interim project managers, from left: 
Rachael Cahill, Brede Quirke, Kay Bailey, 
Brian Murphy, Minister Curran, Michelle O’Brien 
and Susan Collins.
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Rape in Ireland – what role does 
alcohol play?
The Rape Crisis Network Ireland launched its report, Rape 
and justice in Ireland: a national study of survivor, prosecutor 
and court responses to rape, on 7 December 2009.1 The main 
aim of this study was to gather information about the causes 
of attrition in rape cases, to facilitate the development of a 
coherent response to the problem of rape in Ireland. The 
secondary aims were to build a more precise profi le of rape 
in Ireland and to evaluate the experiences of victims who 
engage with the criminal justice system.
There were three strands to this study:
100 individual rape victims were interviewed about their  ■
experience of the legal process.
597 fi les on reported rapes received by of the Director  ■
of Public Prosecutions (DPP) from 2000 to 2004 were 
studied.
173 Central Criminal Court cases from 2000 to 2005  ■
and 35 transcripts of contested trials were analysed.
Results
Interviews with rape victims
All of the 100 rape victims interviewed were female,  ■
half were single, and the median age was 27. Over 
two-thirds of the incidents occurred in houses, with 
the victim’s own home being the single most common 
location. Two-thirds were raped by someone known to 
them. 
In 70% of cases the victim reported that she had been  ■
drinking prior to the incident; 16% had consumed two 
drinks or less, 25% had consumed 3–5 drinks and 29% 
had consumed six drinks or more. In 58% of cases the 
victim reported that the offender had been drinking; 
24% stated that the offender had consumed a moderate 
amount of alcohol; and a further 24% stated that the 
victim had been drinking a lot at the time of the assault. 
Two-thirds of the victims informed the gardaí about the  ■
rape and 49% pursued the case.
Analysis of DPP fi les
Rates of alcohol consumption among complainants  ■
were high: over 80% had consumed alcohol around 
the time of the offence, with 45% described as severely 
intoxicated. These fi ndings place Irish complainants of 
rape at the top of the list for alcohol consumption, when 
compared with British and United States studies.
The majority of suspects were intoxicated at the time  ■
of the offence, with 41% severely intoxicated and 27% 
moderately intoxicated. 
The DPP prosecuted three out of every 10 reported rapes,  ■
and the main reason for failure to prosecute was lack 
of evidence. 
Uncertainty about the incident or about consent due to  ■
excessive alcohol consumption was cited as a factor in 
the failure to prosecute in many cases.
Analysis of Criminal Court cases
Analysis of these cases found high levels of alcohol  ■
consumption by both complainants and defendants. 
There was reluctance among juries to convict unless the  ■
rape conformed to the stranger-rape stereotype. 
Conclusions
The relationship between alcohol consumption and sexual 
violence is complex and caution should be taken before 
concluding that alcohol is a causal factor in rape. Those 
who drink heavily may fi nd themselves in situations that are 
more likely to lead to an assault, such as socialsing in a pub 
or at a party. Nevertheless, alcohol is a disinhibitor and can 
increase aggression, which may increase the likelihood of an 
individual committing a rape. 
The results of this study indicate that alcohol consumption, 
especially drinking to intoxication, is a feature in a high 
proportion of rapes committed in Ireland. Alcohol use also 
decreases the likelihood of the victim reporting the rape and 
increases the likelihood of blame being attributed to the 
victim. Research has shown that 58% of clients attending 
the Sexual Assault Treatment Unit in the Rotunda Hospital in 
2003 had consumed more than four drinks; alcohol has also 
been found to be involved in approximately half of all cases 
of adult sexual abuse. 
The authors of the report highlight that Ireland’s drinking 
culture needs to be tackled, particularly as it affects the 
behaviour of potential perpetrators. They also recommend 
that young men be targeted by a media campaign to make 
them aware that rape is a possible consequence of binge 
drinking, and to remind them that they are responsible for 
their own actions, and that voluntary intoxication does not 
relieve them of that responsibility, morally or legally. 
(Deirdre Mongan) 
Hanly C, Healy D and Scriver S (2009) 1. Rape and justice in 
Ireland: a national study of survivor, prosecutor and court 
responses to rape. Dublin: The Liffey Press.
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The Family Support Network (FSN) held its 11th annual 
Service of Commemoration and Hope on 1 February in 
remembrance of loved ones lost to drugs and related causes 
and to publicly support families living with the devastation 
that drug use causes. The theme of the service this year was 
‘Families: The catalyst for change’.
The service was held in Our Lady of Lourdes Church, Sean 
McDermott Street. The congregation was welcomed by 
Fr. Thomas Grzegorzewski. The large attendance included 
Mr John Curran TD, Minister of State with responsibility 
for the National Drugs Strategy, Garda Commissioner 
Fachtna Murphy, the Lord Mayor of Dublin, Emer 
Costello, the Taoiseach’s aide-de-camp Commandant 
Michael Treacy, Archbishop Diarmuid Martin and other 
religious representatives, and family members, friends and 
representatives from family support groups, and people 
working in this area. 
Sadie Grace of FSN spoke about the importance of acting on 
the information now available on drug-related deaths and 
the urgent need to put measures 
in place to tackle this issue. She highlighted the importance 
of the family in preventing children becoming addicted, 
and stressed the family’s need for support and resources 
in this role. She urged that all children should be 
‘cherished equally’. 
Ruaidhri McAuliffe addressed the audience on behalf 
of the drug-users’ forum, Uisce (Union for Improved 
Services, Communication and Education). Minister Curran, 
Archbishop Martin and Fr Edmond Grace also addressed 
the gathering. 
Dublin West Community Church Music Group provided the 
music, Mick O’Brien sang his own composition ‘Oh Lord Our 
Youth Are Dying’, and John Carmody read a poem that he 
had written. An audio piece entitled ‘Loss’, featuring parents 
who had lost children due to drug use and the effect this 
had on their lives, was played during the service. 
The FSN was announced as an independent organisation in 
November 2007. Formed in 2000 under the auspices of the 
CityWide Drugs Crisis Campaign, the Network consists of 
representatives of family support groups, individual family 
members and those working directly with families of drug 
users. It aims to raise awareness of family support work 
and its role in the community; highlight the importance 
and value of work done by family support groups; provide 
information to families and communities on existing 
services and supports; highlight the extent of the drugs 
problem and its effects on families; campaign for better 
services for drug users and their families; support the 
involvement of the people most affected – drug users and 
their families – in dealing with the problem; and remember 
and commemorate those who have died as a result of drugs. 
There are now over 80 member groups throughout Ireland.
The Family Support Network can be contacted at 
01 836 5168, email info@fsn.ie or at www.fsn.ie
(Suzi Lyons) 
FSN annual Service of Commemoration 
and Hope
 
 
Ruaidhri McAuliffe of UISCE speaking at the 
service (photo: JJ Berkeley)
Sadie Grace of Family Support Network speaking at 
the service (photo: JJ Berkeley)
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Treated problem alcohol use in Ireland: 
ﬁ gures for 2008
Figures from the National Drug Treatment Reporting System 
(NDTRS) for treated problem alcohol use in Ireland in 2008 
by HSE area of residence are currently available on the 
HRB website.1
Some of the main results are:
In total, 7,940 cases were treated for problem alcohol  ■
use in 2007, an increase of 628 on the 7,312 cases 
treated in 2007. This may be attributed to an increase 
in the number of people presenting for treatment, or 
it may refl ect the increase in the number of treatment 
centres participating in the NDTRS in 2008.
Both the incidence and prevalence of treated problem  ■
alcohol use among 15–64-year-olds increased in each of 
the years between 2004 and 2008. 
The incidence of treated problem alcohol use among  ■
15–64-year-olds living in Ireland, expressed per 100,000 
of the population, increased from 118.3 in 2007 to 
120.0 in 2008 (Figure 1). 
The prevalence of treated problem alcohol use among  ■
15–64-year-olds living in Ireland, expressed per 100,000 
of the population, increased from 222.6 in 2007 to 
243.3 in 2008 (Figure 1). 
These increases in incidence and prevalence may be 
explained by an increase in problematic alcohol use in the 
population, an increase in reporting to the NDTRS, or a 
combination of both.
Almost one in fi ve of those treated for problem alcohol use 
in 2008 also reported using at least one other substance, 
a similar proportion to that observed in 2007 and 2006. 
In 2008, the most common additional drugs used by treated 
alcohol cases were cannabis, cocaine, ecstasy and opiates. 
This ranking refl ects a minor change since 2007, when 
benzodiazepines were the fourth most common additional 
drug. Use of more than one substance increases the 
complexity of cases and leads to poorer outcomes for the 
patient. Information about combinations of substances used 
is important in terms of individual clients’ care plans.
In 2008, the median age at which both new and previously 
treated cases began drinking was 16 years, similar to 
previous years. 
The age profi le of cases treated for problem alcohol use was 
the same in 2007 and 2008. The median age for all treated 
cases was 39 years; for new cases, the median age continued 
to be younger (36 years). While the proportion of cases 
under the age of 18 remained small, the number of new 
cases in that age group continued to rise. The majority of 
those treated for problem alcohol use were male, with low 
levels of employment. 
Signifi cant improvements in the NDTRS data collection 
processes and procedures mean that the HRB is now able to 
report on the information collected from alcohol treatment 
services on a more regular basis.  
(Anne Marie Carew)
Alcohol and Drug Research Unit (2010) 1. Treated problem 
alcohol use in Ireland: fi gures for 2008 from the National 
Drug Treatment Reporting System. Dublin: Health 
Research Board. Available at www.drugsandalcohol.
ie/12770
Figure 1 Incidence and prevalence of treated problem alcohol use, per 100,000 of the 15–64-year-old population 
(NDTRS 2004–2008; CSO 2007, 2009)
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Figures from the National Drug Treatment Reporting System 
(NDTRS) for treated problem drug use in Ireland in 2008 by 
HSE area of residence are currently available on the 
HRB website.1
Some of the main results are: 
In total, 14,518 cases were treated in 2008, of whom  ■
6,576 entered treatment in that year. The majority of 
cases attended outpatient services.
The prevalence of treated problem drug use among  ■
15–64-year-olds living in Ireland, per 100,000 of the 
population, increased by 5%, from 444 in 2007 to 466 
in 2008.
New cases entering treatment are an indirect indicator  ■
of recent trends in problem drug use. The incidence of 
treated problem drug use among 15–64-year-olds living 
in Ireland, per 100,000 of the population, increased from 
79.6 in 2007 to 85.8 in 2008.
An opiate (mainly heroin) was the most common main 
problem drug reported by cases entering treatment. Alcohol 
was reported as an additional problem substance in 41.4% 
of all treated cases. The majority of cases treated in 2008 
reported problem use of more than one substance (70.0%), 
which was almost 3% higher than the 2007 fi gure. Cannabis 
(40.7%) and cocaine (36.8%) were the two most common 
additional problem drugs reported in 2008. The proportion 
of cases treated for benzodiazepines as an additional 
problem substance increased by 7.5% between 2007 and 
2008. Polysubstance use increases the complexity of these 
cases, and is associated with poorer treatment outcomes. 
In total, 561 new injector cases entered treatment in 2008, 
an increase of 88 cases on the 2007 fi gure. More than 
two in fi ve of these cases were still injecting on entry to 
treatment, and 43% reported sharing injecting equipment, 
a decrease on the 2007 fi gure. 
Many problem drug users in treatment are young and 
male, have low levels of education and are unlikely to 
be employed.
Over 14% of new cases and more than 3% of previously 
treated cases in 2008 were aged under 18 years, a slight 
increase on the 2007 fi gure in both cases. The proportion 
of new cases in employment decreased by more than 5% 
between 2007 and 2008.
Signifi cant improvements in the NDTRS data collection 
processes and procedures mean that the HRB is now able to 
report on the information collected from treatment centres 
on a more regular basis.
(Anne Marie Carew)
Alcohol and Drug Research Unit (2010) 1. Treated problem 
drug use in Ireland: fi gures for 2008 from the National 
Drug Treatment Reporting System. Dublin: Health 
Research Board. Available at www.drugsandalcohol.
ie/12771.
Treated problem drug use in Ireland: 
ﬁ gures for 2008
Trends in alcohol and drug admissions 
to psychiatric facilities
Activities of Irish psychiatric units and hospitals 2008, the 
annual report published by the Mental Health Research Unit 
of the Health Research Board in December 2009, shows 
that the total number of admissions to inpatient care has 
continued to fall.1 
In 2008, 2,497 cases were admitted to psychiatric facilities 
with an alcohol disorder, of whom 789 were treated for 
the fi rst time. Figure 1 presents the rates of fi rst admission 
between 1990 and 2008 of cases with a diagnosis of alcohol 
disorder, per 100,000 of the population.1-7 It is notable that 
the rate decreased fairly steadily in the period 1992 to 2004 
and more than halved over the 12 years. 
The rate stabilised in 2004 and 2005, but decreased again 
in the years 2006 to 2008. The trend since the early nineties 
refl ects changes in the policy and practice of alcohol 
treatment, and the resultant increase in community-based 
and special residential alcohol treatment services. Of the 
2,392 discharges of cases with an alcohol disorder in 2008, 
just under 42% spent less than one week in hospital and 
19% spent more than one month in hospital. Whether or 
not these admissions were appropriate, and in line with 
the recommendations of the mental health policy, A vision 
for change, could not be discerned from the report as the 
numbers with co-morbid illness were not reported.
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Figure 1 Rates of psychiatric fi rst admission of cases with a diagnosis of alcohol disorder (using the ICD-10 
three-character categories) per 100,000 of the population in Ireland, NPIRS 1990–2008
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Trends in alcohol and drug admissions to psychiatric facilities (continued) 
In 2008, 778 cases were admitted to psychiatric facilities 
with a drug disorder, of whom 289 were treated for the fi rst 
time. The report does not present data on drug use and 
psychiatric co-morbidity, so it is not possible to determine 
whether or not these admissions were appropriate. Figure 2 
presents the rates of fi rst admission between 1990 and 2008 
of cases with a diagnosis of drug disorder, per 100,000 of 
the population.1-6 The rate was almost three times higher 
in 2001 than it was in 1990. Notable dips in the rate occur 
in the census years 1996, 2002 and 2006, and can be partly 
explained by the increased population fi gure used as the 
denominator in calculating the rate for those years.
The overall increase in the rate of drug-related fi rst 
admissions between 1990 and 2001 refl ects the increase 
in problem drug use in Ireland and its burden on the 
psychiatric services. The overall decrease in the rate since 
2001 possibly refl ects an increase in community-based 
specialised addiction services during this period. The 
increased rate in 2005 may be accounted for by the use of 
the 2002 census fi gure in calculating the rate. The decrease 
to 5.9 in 2006 refl ects the new census fi gure used as 
denominator. The rate increased marginally to 6.8 in 2008. 
Of the 791 discharges with a drug disorder, 51% spent less 
than one week in hospital and just under 15% spent more 
than one month in hospital.
(Jean Long)
Daly A and Walsh D (2009) 1. Activities of Irish psychiatric 
units and hospitals 2008. Dublin: Health Research 
Board http://www.hrb.ie/publications/hrb-publication/
publications//495/
Daly A, Walsh D and Moran R (2008) 2. Activities of Irish 
psychiatric units and hospitals 2007. Dublin: Health 
Research Board.
Daly A, Walsh D and Moran R (2007) 3. Activities of Irish 
psychiatric units and hospitals 2006. Dublin: Health 
Research Board.
Daly A, Walsh D, Ward M and Moran R (2006) 4. Activities 
of Irish psychiatric units and hospitals 2005. Dublin: 
Health Research Board.
Daly A, Walsh D, Comish J, Kartalova-O’Doherty 5. 
Y, Moran R and O’Reilly A (2005) Activities of Irish 
psychiatric units and hospitals 2004. Dublin: Health 
Research Board.
Daly A, Walsh D, Moran R and Kartalova-O’Doherty Y 6. 
(2004) Activities of Irish psychiatric services 2003. Dublin: 
Health Research Board.
Walsh D and Daly A (2004) 7. Mental illness in Ireland 
1750–2002: refl ections on the rise and fall of institutional 
care. Dublin: Health Research Board.
Figure 2 Rates of psychiatric fi rst admission of cases with a diagnosis of drug disorder (using the ICD-10 
three-character categories) per 100,000 of the population in Ireland, NPIRS 1990–2008
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How effectively is policy being implemented? 
Concerned at the slow progress in implementing Ireland’s 
national mental health policy A vision for change, launched 
in 2006, and the consequences for the quality of mental 
health services available to service users, the Mental Health 
Commission (MHC) commissioned a study to explore 
the central issues, present the evidence base for effective 
implementation and highlight possible ways to speed up 
implementation. The resulting report was published in 
November 2009.1 
This article outlines the analytical framework presented in 
the MHC report. Although intended to be applied in the 
mental health fi eld, the framework is a generic evidence-
based implementation framework, which may be applied 
equally to other policy domains such as drugs and alcohol 
policy. It identifi es six specifi c tasks and activities associated 
with effective implementation:
attention to implementation in the policy formulation  ■
process,
skilled leadership in the implementation process, ■
appropriate support and governance arrangements, ■
adequate resources, ■
a detailed plan, and ■
continuous communication.  ■
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How effectively is policy being implemented? (continued)
These tasks and activities occur in three broad stages – 
the policy formulation process prior to implementation, 
implementation and monitoring – as summarised in the 
diagrammatic representation below. The twelve 
tasks listed in this diagram are elaborated on in the 
following paragraphs.
Policy formulation process
Make implementation an important consideration during 1. 
policy design – this includes identifying different means 
of achieving policy objectives and identifying barriers to 
implementation. 
Involve as many stakeholders as possible in policy 2. 
formulation process – including, and consulting with, 
stakeholders serves to inform the policy and also the 
implementation of the policy. 
Disseminate the policy3.  – all stakeholders need to know 
about the new policy.
Generate political support and funding4.  – active stakeholder 
participation and communication activities are important 
in achieving this. Political leadership and support can be 
crucial in ensuring implementation.
Implementation
Appoint a leader and an implementation team5.  – the 
World Health Organization (WHO) reports that a 
multidisciplinary team to implement policy has proved 
successful in several countries.
Establish an implementation structure6.  – This national 
team should be echoed regionally and locally with, at a 
minimum, a regional leader and local leaders. 
Provide the necessary resources7.  – this includes an 
appropriately crafted budget, including managing 
contingency funding and fi nancial risk. It is also 
strongly recommended that appropriately skilled and 
experienced fi nancial management personnel should be 
part of the implementation team.
Prepare a plan8.  – an implementation plan should provide 
a map of how the policy will be implemented and 
should deal in suffi cient detail with:
timeframes, including the different phases for • 
implementation,
roles and responsibilities of those involved in • 
implementation,
resources, including funding and human resources,• 
risk management, including how any potential • 
barriers to implementation will be addressed,
monitoring and reporting requirements.• 
Communicate 9. – on-going communication is critically 
important to implementation because it is an effective 
tool for motivating employees, for over-coming 
resistance to an initiative, for preparing employees 
for the pluses and minuses of change and for giving 
employees a personal stake in the process. 
Include stakeholders and promote stakeholder 10. 
interaction – the purpose of stakeholder inclusion in the 
implementation process must be clear so that the right 
stakeholders can be identifi ed. For example, is their 
inclusion to obtain support, to provide a communication 
channel or to test the design or roll-out?
Support interdepartmental co-ordination11.  – Where cross-
agency implementation is necessary, the likelihood 
of effective implementation is greater where there is 
a high-level implementation plan involving the 
relevant agencies. 
Monitoring
Put in place a governance structure12.  – governance 
arrangements are required to ensure adequate reporting 
and review mechanisms. Monitoring is essential to 
determine if the desired outcomes are being achieved 
and also to identify risks to implementation so that 
corrective action can be taken. 
(Brigid Pike)
Mental Health Commission (2009) 1. From vision to action? 
An analysis of the implementation of A vision for change. 
Dublin: Mental Health Commission.
Pre-implementation: Policy Design
Consider implementation during policy design
Involve stakeholders in policy design
Disseminate the policy
Generate political support & funding
Monitoring
Put in place a monitoring structure
Appoint a leader and implementation team
Establish an implementation structure
Provide the necessary resources
Prepare an implementation plan
Communicate
Include stakeholders and promote interaction
Support interdepartmental co-ordination
Implementation
Figure 1 Evidence-based factors supporting successful implementation
 Source: Mental Health Commission (2009)
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Health proﬁ le of people using Cork 
Simon services
The Cork Simon Community, which works with homeless 
people, undertook a health audit of clients using the 
service in the fi rst week of September, 2009.1 A total of 183 
individuals were supported by services throughout the week; 
86% were male, 87% had a medical card, and 63% were in 
receipt of a social welfare disability allowance. 
Table 1 presents a breakdown of the overall fi gure by type 
of service used, health status and substance use. Individuals 
using high-support accommodation were more likely to have 
a diagnosed physical or mental health condition; all of this 
group had medical cards, and the group had the highest 
proportion of people receiving disability benefi t. Rates of 
alcohol use were relatively high among all service users. 
Long-term homelessness 
In the week of the health audit, 36% (n=20) of the residents 
in the Emergency Shelter were long-term homeless, defi ned 
by the strategy on homelessness as being in emergency 
accommodation for more than six months. All 20 were male; 
80% had a medical card; 60% were receiving a disability 
payment; 55% had at least one diagnosed physical health 
condition; 55% had at least one diagnosed mental health 
condition; 90% used alcohol and 55% used drugs; 55% had 
a diagnosed mental health condition and used alcohol and/
or drugs. 
Rough sleepers
Sixteen people were recorded as sleeping rough for at least 
one night during the week of the audit, of whom six were 
consistent rough sleepers. Fifteen were male; 50% had a 
medical card; 31% were in receipt of a disability payment; 
56% had a diagnosed physical health condition; 44% had 
a diagnosed mental health condition; 81% used alcohol 
and 56% used drugs; 44% had a diagnosed mental health 
condition and used alcohol and/or drugs. 
Conclusion
This snapshot taken by the Cork Simon Community over the 
course of a week provides useful information on health and 
related behaviours among homeless people in Cork. Overall, 
the data paint a picture of poor physical and mental health, 
high dependence on social welfare payments, relatively 
high levels of alcohol and drug use and, for some, unstable 
accommodation. The relatively high prevalence of substance 
use among people who are long-term homeless and/or 
sleeping rough may exacerbate their situation and prolong 
their experience of homelessness. Individuals presenting 
with diagnosed mental health conditions who are substance 
users are also a concern. On a slightly brighter note, among 
the people who are being helped with independent living, 
the outcomes are less severe, as this group reports lower 
levels of heavy alcohol use and lower levels of drug use 
and heavy drug use compared to people in emergency 
accommodation. This snapshot demonstrates the myriad 
needs that homeless people with substance use problems 
can present with and highlights the enduring challenge 
facing service providers in responding to these needs and 
reducing the associated harms. 
(Martin Keane)
Cork Simon Community (2009) 1. Sick and tired of 
homelessness: health profi le of people using Cork Simon 
services. Cork: Cork Simon Community. Available at www.
drugsandalcohol.ie/12798/
Table 1 Health profi le of users of Cork Simon services, September 2009
Service No. of clients Diagnosed 
physical 
condition
Diagnosed 
mental condition
Alcohol use Drug use
n n (%) n (%) n (%) n (%)
Emergency Shelter 55 21 (38) 20 (36) 43 (78) 24 (44)
High support 
(5 houses)
43 37 (86) 34 (79) 37 (86) 20 (47)
Housing Plus* 79 28 (35) 50 (67) 64 (81) 25 (32)
*Includes Simon and Galton fl ats for independent living (38 clients), private rented accommodation (21 clients), 
council accommodation (7 clients) and ‘other’ (13 clients). 
Source: Data from Cork Simon Community (2009)
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Debt-related intimidation of drug users 
and their families
In 2009 the Family Support Network (FSN)1 published the 
fi ndings of research into the issue of intimidation of the 
families of drug users by those involved in drug dealing.2 
Through its work, the FSN became aware of a large number 
of families experiencing intimidation by drug dealers as a 
result of a family member’s drug-related debts. The research 
consisted of a postal survey of 91 family support workers or 
facilitators, of whom 50 responded – a response rate of 55%.
The study found that no locality or region from which 
responses were received was untouched by intimidation. Of 
the 50 survey respondents, 30 knew of cases of intimidation 
in relation to debts of €500 or less. At the other end of the 
scale, 16 respondents were aware of cases relating to debts 
of between €10,000 and €40,000, and one respondent 
reported a case involving €60,000. Many of those in debt 
belonged to families surviving on very low incomes, who 
were often given only days to repay the debt. Drug users 
themselves often resorted to criminal activity to repay debts 
to dealers: many agreed to deal drugs or to hide, hold or 
transport drugs or fi rearms for the dealer to whom they 
owed money. Others engaged in violent activity, including 
murder in one case, as a method of repayment. Many 
female drug users engaged in prostitution to repay their 
debts. 
Respondents were asked to list the types of intimidation 
experienced by families they encountered. The resulting lists 
included verbal threats, physical violence and damage to the 
home or other property. Seven respondents were aware of 
cases in which individual family members had experienced 
sexual violence or threats of such violence. Thirty-fi ve 
respondents reported cases of intimidation in which 
mothers of drug users were targeted; 23 reported targeting 
of siblings; 21 reported targeting of fathers; 17 reported 
targeting of grandparents and children; and 10 reported 
targeting of partners and others. 
The report identifi ed a number of issues complicating both 
the impact of intimidation and the responses available 
to families. Because the debt was normally collected by 
a person working for the dealer, it was not always easy 
for families to know to whom the money was owed or 
whether the money was being given to the correct person. 
In deciding whether or not to pay a debt, families were 
infl uenced by their assessment of whether the intimidation 
would stop once payment was made, as ‘many families are 
caught in a recurrent cycle of debt, intimidation, repayment 
and further debt’ (p. 22). Fear often stemmed from 
knowledge of the perpetrators and their capacity to follow 
through on threats. Fifty-one per cent of respondents stated 
that threats were sometimes carried out; 33% that threats 
were always carried out; and 4% that they were never 
carried out.
Table 1 shows the various ways that families sourced the 
money to pay a debt on behalf of a family member, as 
reported by the survey respondents (six respondents were 
not aware of any such cases). In the case of social welfare 
payments, including children’s allowances and disability 
payments, the intimidators sometimes waited outside social 
welfare offi ces on collection days to collect the debt.
Table 1 Sources of funds used by families to pay drug debts
Source of funds Respondents who reported each source
n %
Credit union loan 36 72
Borrowing from family/friends 33 66
Salary/wages 25 50
Social welfare payments 22 44
Borrowing from money lender 21 42
Sale of personal property 17 34
Re-mortgaging of home 11 22
Bank loan 9 18
Other 3 6
Not applicable 6 12
Source: Adapted from O’Leary (2009: 23)
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Debt-related intimidation of drug users and their families (continued) 
The study identifi ed a number of themes through a case 
study analysis of reported incidents of intimidation. 
These included the following:
Threatening behaviour•  included verbal threats, 
intimidation at the workplace, harassment, death 
threats, threats of shooting, beating or ‘knee-
capping’, and live bullets posted through letterboxes.
Physical/sexual violence against women•  included 
the forcing of drug users and partners into 
prostitution; two minors under 18 years of age were 
forced into prostitution; one dealer threatened to 
rape the daughter of a drug user.
Children•  were encouraged by dealers to deal to 
friends or other children so as to create debt and 
force them into further dealing; children were often 
present when family members were beaten; in some 
cases mothers engaged in prostitution in the family 
home as a means of debt repayment.
Garda reaction•  – family members were too fearful 
to approach gardaí in relation to intimidation; many 
believed the gardaí were powerless to act; in one 
case gardaí advised a family to pay the debt, while in 
another they provided protective custody to a family 
and a drug user.
Women • – perpetrators of intimidation targeted 
female drug users for debt repayment, in some 
cases forcing them, either directly or indirectly, into 
prostitution; a high proportion of families targeted 
were headed by a female lone parent; average 
weekly earnings of females were signifi cantly less 
than their male counterparts and women were 
more likely to be out of the workforce; women often 
concealed intimidation and payment from their 
husbands/partners owing to fear that he might not 
be willing to pay. 
Forced emigration•  – in many cases drug users had 
been forced to move or emigrate and were unable to 
return home.
The report called for a pilot initiative whereby the gardaí 
would identify a member of staff to liaise with families 
experiencing intimidation. A safe reporting and advice-
provision procedure for families willing to report the issue 
and/or pursue it through the legal system was also called for. 
The intimidation of drug users and their families has been 
highlighted as a key issue in the National Drugs Strategy 
2009–2016.3
(Johnny Connolly)
The FSN was established in 2000 to support the 1. 
development of family support groups throughout 
Ireland. There are currently over 70 family support 
groups affi liated to the FSN.
O’Leary M (2009) 2. Intimidation of families. Dublin: Family 
Support Network. Available at www.drugsandalcohol.
ie/12898 
Department of Community, Rural and Gaeltacht 3. 
Affairs (2009) National Drugs Strategy (interim) 2009–
2016. Dublin: Department of Community, Rural and 
Gaeltacht Affairs.
Newly diagnosed drug-related viral 
hepatitis infections in 2008
Hepatitis B 
Hepatitis B is a vaccine-preventable disease which is 
transmitted through contact with the blood or body fl uids 
of an infected person. The main routes of transmission are 
mother-to-baby, child-to-child, sexual contact and unsafe 
injections. The number of cases notifi ed to the Health 
Protection Surveillance Centre (HPSC) increased each year 
between 1996 and 2005. In 2006 the number decreased by 
7% (to 810) and then increased steadily in 2007 and 2008. 
There were 949 cases in 2008, of whom 765 had a chronic 
infection, 82 had an acute infection and the disease status 
of 102 cases was unknown (unpublished data from the 
HPSC). The surveillance system has recorded risk factor data 
since 2004 and the number of cases notifi ed to the HPSC 
that include data on risk factors has increased from 30% in 
2006 to 59% in 2008. In 2008, 59% (557) of all cases had 
risk factor data reported, of whom seven (1.3%) reported 
injecting drug use as their main risk factor. The number of 
such cases remained consistently low between 2005 and 
2008, indicating the effectiveness of routine administration 
of the hepatitis B vaccine.
Hepatitis C 
Hepatitis C is transmitted through contact with the blood 
of an infected person, the main routes of transmission being 
mother-to-baby, unsafe injections, transfusion of blood and 
blood products, and unsterile tattooing and skin piercing. 
It is one of the most common blood-borne viral infections 
among drug users. There were 1,537 cases of hepatitis C 
reported to the HPSC in 2008, compared to 1,128 cases in 
2004 (Table 1), and 85 cases of hepatitis ‘type unspecifi ed’ 
in 2003. 
Table 1 Number of hepatitis C cases and age-
standardised notifi cation rates (ASR) per 
100,000 population, 2004–2008
Year Number of cases ASR per 100,000
2004 1128 26.6
2005 1415 33.4
2006 1219 28.8
2007 1556 36.7
2008 1537 36.3
Source: Unpublished data from the HPSC
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Table 3 Hepatitis C cases who reported injecting drug use, by age, gender and place of residence, 2007 and 2008
Risk factor status 2007
n (%)
2008
n (%)
Total number of known injector cases 503 447
Gender 
Male 339 (67.4) 319 (71.4)
Female 163 (32.4) 126 (28.2)
Unknown 1 (0.2) 2 (0.4)
Age
Mean (in years) 32.7 33.3
Median (in years) 31 32
Under 25 years 49 (9.7) 45 (10.1)
25–34 years 282 (56.1) 233 (52.1)
Over 34 years 170 (33.8) 165 (36.9)
Unknown 2 (0.4) 4
Place of residence
Dublin, Kildare and Wicklow 445 (88.5) 379 (84.8)
Elsewhere in Ireland 58 (11.5) 68 (15.2)
Source: Unpublished data from the HPSC
(Jean Long)
An enhanced surveillance system for hepatitis C was 
introduced in Ireland in 2007. Enhanced surveillance 
is essential to identify risk factors and to inform the 
development of prevention and treatment strategies. In 
2008, 38% of newly-reported hepatitis C cases had risk 
factor status reported (Table 2). As expected, the majority 
(76.9%) of these cases reported injecting drug use as the 
main risk factor. Four per cent of cases said that they had 
been recipients of blood or blood products at some time in 
the past and, according to the HPSC, were late reports to the 
system (N Murphy, HPSC, personal communication, 2009). 
Table 2 Number (%) of hepatitis C cases reported to the HPSC, by risk factor status, 2007 and 2008
Risk factor status 2007
n (%)
2008
n (%)
Total number of cases 1556 1537
Cases with reported risk factor data 664 (42.7) 581 (37.8)
Of which:
Injecting drug users 503 (75.8) 447 (76.9)
Recipients of blood/blood products 34 (5.1) 24 (4.1)
Other risk factors 90 (13.6) 77 (13.3)
No known risk factor identifi ed 37 (5.6) 33 (5.7)
Cases without reported risk factor data 892 (57.3) 956 (62.2)
Source: Unpublished data from the HPSC
In 2007, 85% of cases who reported injecting drug use as their main risk factor were notifi ed to the HPSC by services in 
Dublin, Kildare and Wicklow and the remainder by services in HSE areas outside these counties (Table 3). Seventy-one 
per cent were male and 62% were under 35 years old. 
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On 15 December 2009 the Drug Treatment Centre Board 
announced the graduation of two of its nurses as Nurse 
Prescribers in Addiction.1 This treatment centre is the 
fi rst addiction service in Ireland to have qualifi ed nurse 
prescribers. Making the announcement, the Board’s general 
manager, Sheila Heffernan, said: ‘Our range of services, 
specialist teams and dedication to excellence has positioned 
us perfectly to become the fi rst to introduce nurse 
prescribing in addiction nationally.’
The 1998 report, Review of scope of practice for nursing and 
midwifery,2 produced by An Bord Altranais recommended 
that nurse prescribing be introduced in Ireland. 
Internationally, this practice has been seen to improve 
the quality of patient care when used in appropriate 
circumstances. The advantages of nurse prescribing in 
addiction services include increased access to services for 
clients, improved continuity of care, reduced waiting times 
and improved quality of service and care.3 
In May 2007, the Minister for Health signed the legislation 
to provide the legal authority for nurses and midwives to 
prescribe medication: Irish Medicines Board (Miscellaneous 
Provisions) Act 2006 (Commencement) Order 2007 (SI No. 
194 of 2007), Medicinal Products (Prescription and Control 
of Supply) (Amendment) Regulations 2007 (SI No. 201 of 
2007) and Misuse of Drugs (Amendment) Regulations 2007 
(SI No. 200 of 2007).4 
The fi rst cohort of qualifi ed nurse prescribers in Ireland was 
registered in January 2008.5 Prospective nurse prescribers 
must complete an approved six-month course and adhere to 
a set of practice standards and competencies for prescribing. 
In addition, An Bord Altranais requires any health facility 
employing nurse prescribers to have certain support 
structures in place. 
Currently, nurse prescribers cannot prescribe methadone. 
However, they can, where appropriate, prescribe certain 
controlled drugs under specifi c conditions of the Misuse 
of Drugs Regulations, including drugs for the purpose of 
midwifery, such as pethidine, or drugs for palliative care, 
such as morphine sulphate.4 
(Suzi Lyons)
Drug Treatment Centre Board (2009) 1. The Drug 
Treatment Centre Board pioneers fi rst nurse prescribers in 
addiction in Ireland. DTCB online news report dated 15 
December 2009. Accessed 19 February 2010 at www.
dtcb.ie/news
An Bord Altranais (2000) 2. Review of scope of practice 
for nursing and midwifery: fi nal report. Dublin: 
An Bord Altranais. 
Gallagher J, O’Gara C, Sessay M and Luty J (2006) Nurse 3. 
prescribing in addiction services: client benefi ts. 
Nursing Standard, 20(48): 42–44.
For further information please see An Bord Altranais 4. 
website at www.nursingboard.ie An Bord Altranais 
(2008) First registered nurse prescribers. 
An Bord Altranais News, 20(1): 1. 
Drug Treatment Centre Board pioneers 
nurse prescribing in addiction in Ireland
 The two newly-graduated nurse prescribers in 
addiction, Claire Loomes (3rd from left) and 
Jane Bridgeman (6th from left), with their Drug 
Treatment Centre Board colleagues and Maureen 
Flynn of the HSE (2nd from left).
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Legal update 2009
This update covers drug-related Bills and Acts of the 
Oireachtas introduced or progressed in 2009. It also 
identifi es new substances brought under control within the 
terms of the Misuse of Drugs legislation.
The Criminal Justice (Surveillance) Act 2009 provides, for 
the fi rst time, a legal framework to allow covert surveillance 
material to be used in criminal trials. The Garda Síochána, 
the Defence Forces and the Revenue Commissioners will 
have a statutory framework for the operation of secret 
electronic surveillance to combat serious crime as well 
as subversive and terrorist threats against the security of 
the State. The legislation also builds in safeguards with 
regard to the authorisation, duration and operation of such 
surveillance. 
The Criminal Justice (Amendment) Act 2009 makes 
provision to enable all organised crime offences to be 
declared scheduled offences for the purpose of trial in the 
Special Criminal Court, which operates with three judges 
and without a jury. Section 3 of the 2009 Act amends 
section 70 of the Criminal Justice Act 2006 and defi nes 
a ‘criminal organisation’ as ‘a structured group, however 
organised, that has as its main purpose or activity the 
commission or facilitation of a serious offence’. A ‘structured 
group’ is defi ned as ‘a group of 3 or more persons, which 
is not randomly formed for the immediate commission of a 
single offence, and the involvement in which by 2 or more 
of those persons is with a view to their acting in concert; 
for the avoidance of doubt, a structured group may exist 
notwithstanding the absence of all or any of the following:
a)  formal rules or formal membership, or any formal 
roles for those involved in the group;
b) any hierarchical or leadership structure;
c)  continuity of involvement by persons in 
the group.’
In relation to bail, organised crime offences will be 
scheduled as ‘serious offences’ within the meaning of the 
Bail Act 1997, thereby providing for circumstances where 
bail may be refused by the courts. 
In its passage through the Oireachtas, this legislation gave 
rise to a number of criticisms from lawyers and human 
rights groups. With regard to restrictions on the Irish 
constitutional right to trial by jury, the Irish Human Rights 
Commission (IHRC) stated: ‘The IHRC is cognisant that 
organised crime is a problem in Ireland and that it has the 
potential to cause great harm to Irish society. However, the 
IHRC considers that the exigencies of the situation in Ireland 
do not justify the restriction of the Constitutional right to 
trial by jury.’1 The IHRC suggested that with regard to the 
risk of jury intimidation, a number of other measures could 
be adopted to address this potential problem including 
having an anonymous jury, screening the jury from public 
view, protecting the jury during the trial, or locating the jury 
in a different place from where the trial is being held, with 
communication by video link. 
The Criminal Justice (Miscellaneous Provisions) Act 2009 
provides a statutory framework for the control of fi rearms.
The Housing (Miscellaneous Provisions) Act 2009 obliges 
local housing authorities to adopt a strategy to prevent and 
reduce anti-social behaviour in their housing stock, with the 
additional objectives of the co-ordination of services and the 
promotion of co-operation with other agencies to that end. 
The Act also broadens the defi nition of anti-social behaviour 
in the Housing (Miscellaneous Provisions) Act 1997 to 
include signifi cant or persistent impairment of a person’s use 
or enjoyment of their home, and damage to or defacement 
of any property. 
The Health (Miscellaneous Provisions) Act 2009 makes 
arrangements for progressing the integration of health 
service agencies in line with Government policy on the 
rationalisation of public sector agencies. Part 5 of the Act 
provides for the dissolution of the Drug Treatment Centre 
Board and the transfer of its rights, liabilities, land and any 
other assets to the Health Service Executive.
The Criminal Procedure Bill 2009 makes provision for a 
modifi cation of the rule against double jeopardy in order 
to allow a person who has been acquitted of an offence 
to be re-tried in circumstances where new and compelling 
evidence emerges or where the acquittal is tainted due, for 
example, to corruption or intimidation of witnesses or jurors 
or perjury. The legislation applies to a number of drug-
related offences.2 
The Communications (Retention of Data) Bill 2009 
requires service providers, those engaged in the provision 
of a publicly electronic communication service or a public 
communication network by means of fi xed line or mobiles 
or the internet to retain data relating to fi xed and mobile 
telephony, for one year, and data relating to internet access, 
internet email and internet telephony for two years.3
The Criminal Justice (Money Laundering and Terrorist 
Financing) Bill 2009 provides for offences of, and related to, 
money laundering in and outside the State; to give effect to 
Directive 2005/60/EC of the European Parliament and of the 
Council of 26 October 2005 on the prevention of the use of 
the fi nancial system for the purpose of money laundering 
and terrorist fi nancing.
The Road Traffi c Act 2009 provides for a reduction in 
the blood alcohol content (BAC) limit for drivers and also 
provides powers to assist the Garda Síochána in forming an 
opinion as to whether a driver is under the infl uence of an 
intoxicant (drug or drugs) and to carry out a preliminary 
impairment test on such drivers.
New substances brought under control
In March 2009, Minister for Health and Children Mary 
Harney TD announced that 1-benzylpiperazine (BZP) is now 
a controlled drug through statutory instruments (121 and 
122 of 2009) amending the Misuse of Drugs Act 1977, and 
that its possession or sale is now a criminal offence. The 
new statutory instruments will ensure that BZP is no longer 
available for sale in ‘head shops’ around the country or on 
the streets. 
(Johnny Connolly)
Irish Human Rights Commission (2009) 1. Observations on 
the Criminal Justice (Amendment) Bill 2009. Dublin: Irish 
Human Rights Commission. www.ihrc.ie
Bill at Committee stage March 2010.2. 
Bill at Report and Final Stages February 2010.3. 
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Nurses fi rst began working in the Irish Prison Service (IPS) in 
1999. The IPS and the Nursing and Midwifery Planning and 
Development Unit (NMPUDU) of the HSE Eastern Region 
collaborated in a recent study exploring the opportunities 
for the development of nursing services in prisons. The 
results of that study have now been published.1 
The study included a literature review on the role of nurses 
in prison healthcare, a descriptive review of the IPS and 
the professional framework for nursing in Ireland, and a 
quantitative questionnaire completed by nurses and medical 
orderlies working in the IPS (32% response rate). The 
qualitative components were participant observation and 
semi-structured interviews with key informants, including 
prison management and those internally and externally 
involved in prison healthcare. Focus groups were held 
with three groups of nurses and three groups of prisoners. 
Data collection took place between November 2005 and 
December 2007. 
The fi ndings of the study covered a wide range of health 
and professional issues; this article will focus only on the 
results related to substance misuse and addiction. In the 
quantitative questionnaire, care related to substance misuse 
featured in the 14 most frequently performed clinical tasks, 
and was carried out on a daily basis by 50% or more of 
respondents to the questionnaire. More than half of the 
nurse respondents identifi ed addiction as one of the areas 
where specialist training should be developed.
In the qualitative part of the study, participants highlighted 
addiction and its consequences as an important 
healthcare problem. Participants reported that cannabis, 
benzodiazepines and heroin were the most common illicit 
substances used in prisons, although availability varied 
between prison sites. While methadone maintenance 
treatment was available in most prisons, the need for 
improved treatment for problem use of other substances, 
in particular benzodiazepines and alcohol, was raised by 
many participants. Treatment for addiction was reported 
to be inconsistent, with a lack of counselling services2 and 
there was ‘some confusion in relation to approaches to 
detoxifi cation, methadone dose and access to treatment’ 
(p. 82). Most participants reported a need for improved 
education and training in addiction care for nurses. Prisoners 
also highlighted the need for peer support and improved 
discharge planning in relation to addiction care. 
Mental health problems among prisoners, especially those 
who had a dual diagnosis (both a mental health issue and a 
substance use disorder), were identifi ed as a signifi cant and 
challenging health issue by all participant groups. 
The authors conclude that nurses have a very important role 
in addressing the health needs of prisoners. They found that 
there was a strong awareness of the importance of prison 
healthcare and that nurses did receive recognition and 
support from all the stakeholders involved. However, it 
also found that nurses could be used more effectively 
within the IPS.
The report sets out 16 goals for the future development of 
prison nursing and healthcare in Ireland, each with its own 
set of recommendations. The authors state that many of 
the recommendations do not require additional resources 
or funding, but restructuring and integration of existing 
services and resources and effective collaboration at all levels.
The goals are:
Enhance the strategic development of prison healthcare ■
Identify and meet prisoner health needs ■
Develop and implement policies, procedures, protocols  ■
and guidelines
Develop nursing role: ■
role defi nition• 
advance capacity for specialist and advanced nursing • 
practice
advance skills and competencies• 
Develop professional development infrastructure ■
Support practice with the scope of Nursing and  ■
Midwifery Practice Framework
Enhance quality and governance ■
Develop workforce planning ■
Strengthen nursing practice – access ■
Strengthen nursing practice – committal assessment and  ■
care planning
Balance the therapeutic and custody roles ■
Develop prison healthcare infrastructure ■
Implement recommendations. ■
(Suzi Lyons)
Nursing and Midwifery, Planning and Development 1. 
Unit & the Irish Prison Service (2009) Nursing in the Irish 
Prison Service: working together to meet the healthcare 
needs of prisoners. Dublin: Health Service Executive.
Since 2008 Merchants Quay Ireland has provided 2. 
national prison-based addiction counselling services to 
13 prisons.
Report on nursing in the Irish Prison 
Service
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Irish Prison Service annual report 2008
The Irish Prison Service (IPS) annual 
report for 20081 notes a number of 
developments in relation to healthcare 
and drug treatment and reintegration 
services, as well as presenting data 
on drug offenders in custody and 
outlining the enhanced security 
measures in place to prevent access 
to contraband. These sections of the 
report are summarised in this article.
Healthcare services 
The aim of the prison healthcare 
service is to provide prisoners with 
access to the same quality and range 
of health services as that available 
to those entitled to general medical 
services in the community, and which 
are appropriate to the prison setting. 
Nursing 
Nurse managers were in post in 
all closed prisons and in the three 
main prison complexes: Mountjoy, 
Cloverhill and Wheatfi eld, and 
Midlands and Portlaoise. The report 
states that this has signifi cantly 
impacted on the co-ordination, 
organisation and quality of healthcare 
services in the IPS. Specifi c addiction 
nursing posts were also created, 
mainly in Mountjoy prison.
Pharmacy services
Professional pharmacy services were 
available in all except one prison (they 
were to be introduced in Cork prison 
in 2009). In addition, prisoners in 
Mountjoy/Dóchas complex had access 
to a drug treatment pharmacy service. 
This service dispensed methadone to 
approximately 200 patients every day.
Mental health
The report notes the high prevalence 
of mental health problems in the 
prison population and the importance 
of providing care in the most 
appropriate facility. In the latter part of 
2008 some 15 prisoners a week were 
waiting for admission to the Central 
Mental Hospital (CMH). In November 
2008 the HSE agreed to provide 10 
extra beds in the CMH, and although 
these beds were not solely for the use 
of the prisons, they have gone some 
way to reducing the waiting list for 
this service.
In-reach services
In-reach medical services are available 
in a number of 
the prison sites:
Dental services from the Dublin  ■
Dental Hospital – 
in seven Dublin prisons
Consultant-led psychiatric services  ■
from the CMH – 
in all Dublin prisons and in 
Portlaoise/Midlands
Consultant-led addiction services –  ■
in Cloverhill/Wheatfi eld and in the 
Mountjoy complex.
Deaths in custody
In 2008 there were 11 deaths in 
custody, an increase of fi ve on the 
2007 fi gure. The inquests were 
not closed in any of these cases so 
exact cause of death was not known. 
Every death in custody is examined 
by a multi-disciplinary group, and 
signifi cant fi ndings are shared with 
other sites. The report states that there 
are strategies in place to help prevent 
self-harm and suicide. 
Drug treatment services
Merchants Quay Ireland completed 
the implementation of its national 
prison-based addiction counselling 
service in 2008. This service is 
available to all prisoners who require 
it, and provided in excess of 1,000 
counselling hours per month to a total 
of 440 prisoners in 13 prisons in 2008. 
Methadone maintenance treatment 
was available in eight of the 14 
prisons (covering 80% of the prison 
population). The report notes that in 
2008 the IPS was the largest single 
provider of methadone maintenance 
treatment, treating an average of 
650 patients per month, and a total 
of 2,014 in the year (Table 1). This 
represents a 28% increase on 2007 
fi gures. Of these, 241 had never been 
in treatment before (Table 1). 
The IPS published a Drug treatment 
clinical policy in January 2008 
to provide guidance to health 
professionals when treating addiction 
in prison.2 
drugnet 
IRELAND
25
Irish Prison Service annual report 2008 (continued)
Reintegration – homelessness
The report refers to homelessness among ex-prisoners as 
an ongoing problem; 894 prisoners accessed the in-reach 
community welfare service provided by the Homeless 
Persons Unit of the HSE in 2008, an increase of 304 on the 
2007 fi gure. A pilot service run by Focus Ireland in Cloverhill 
prison has provided a case management and pre-settlement 
service for 68 homeless remand prisoners since it started in 
September 2007.
Drug offenders in custody
On 5 December 2008 there were 567 people (550 males 
and 17 females) serving sentences for drug offences – 15% 
of the total number (3,695) in custody on that date, and 
20% more than the comparable fi gure of 472 in 2007. 
During 2008, 637 people (595 males and 42 females) 
were committed under sentence for drug offences, 
representing 8% of total committals under sentence in the 
year, compared to 8.2% in 2007. Thirty-six drug offenders 
were committed under sentence of more than 10 years, 
an increase on the 2007 fi gure of 22. Table 2 shows the 
numbers in custody on 5 December 2008 and the 
numbers committed during 2008, by sentence length.
Security measures
The roll-out of a package of enhanced security measures 
in closed prisons to prevent access to contraband items, 
primarily mobile phones, drugs and weapons, began in 
May 2008. The new measures include operational support 
(dedicated search teams), security screening (airport-style 
detectors and scanners) and drug-detection dog teams (16 
teams came into operation in 2008). Some 2,047 mobile 
phones were seized by prison authorities in 2008. The fi rst 
module of a pilot project to install technology to prevent the 
use of mobile phones was completed in the Midlands prison 
in November 2008, and a second module was started in 
Portlaoise prison. 
There were 759 incidents of violence among prisoners, some 
of them very minor. According to the report, ‘Attacks by 
prisoners on prisoners are often related to matters on the 
outside – such as drug debts or gang rivalry, or perceived 
co-operation with Gardaí.’
(Suzi Lyons and Joan Moore)
Irish Prison Service (2009) 1. Irish Prison Service annual 
report 2008. Longford: Irish Prison Service. 
This document can be found at www.irishprisons.ie/2. 
Healthcarepolicies060209.doc
Table 2 Numbers serving sentences for drug offences, by sentence length, 2008
Drug offenders <3 
months
3–6 
months
6–12 
months
1–2 
years
2–3 
years
3–5 
years
5–10 
years
10+ 
years
Total
In custody on 
5 December 2008
4 3 22 33 60 133 220 92 567
Committed under 
sentence in 2008
139 61 133 53 59 77 79 36 637
Table 1 Numbers of individuals receiving methadone treatment* in Irish prisons in 2008
Prison Total patients during 2008 New patients in 2008 Patients at 31 December 
2008
Cloverhill Prison 827 168 71
Dóchas Centre 245 27 25
Limerick Prison 37 6 12
Midlands Prison 110 5 50
Mountjoy Main Prison 464 12 171
Mountjoy Medical Unit 89 5 19
Portlaoise Prison 4 1 1
St Patrick’s Institution 28 5 8
Wheatfi eld Prison 210 12 95
Total 2014 241 452
*Methadone treatment in this context is either substitution or detoxifi cation.
Source: IPS (2009) 
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‘The State Laboratory provides an 
analytical and advisory service to 
Government departments and offi ces 
to support their policies, regulatory 
programmes and strategic objectives’.1 
The laboratory’s annual report for 2008 
outlines the progress made in achieving 
its objectives in four strategic areas: 
agriculture and food, Revenue, the 
Coroner Service and other departments, 
and the modernisation agenda and 
operational capacity.2 
The human toxicology department of 
the laboratory provides services to the 
Coroner Service, the Department of 
the Environment, the Department of 
Agriculture and other bodies such as the 
Irish Medicines Board. Between 2007 and 
2008 the laboratory saw a 6% increase 
in the number of samples received 
for analysis. The laboratory extended 
its analytical capacity in 2008 with 
the development of a number of new 
methods of analysis.
The number of post-mortem samples 
analysed for the Coroner Service which 
were positive for cocaine remained high, 
indicating the widespread use of the drug. 
Requests for post-mortem analysis of 
benzylpiperazine (BZP) were encountered 
for the fi rst time by the laboratory. 
BZP (also known as legal ecstasy) is an 
amphetamine-type drug which, until 
March 2009, could be purchased legally 
in Ireland in the form of party pills. In 
2009, legislation was passed making BZP 
and related compounds illicit substances 
under the Schedule of Controlled 
Substances in the Misuse of Drugs Act.
The goal of the laboratory with regard 
to the Coroner Service remains that of 
providing a timely, high-quality service 
and to meet present and future demands 
in areas such as forensic toxicology, health 
and safety compliance, and environment 
and heritage protection.
(Simone Walsh)
The State Laboratory (2008) 1. Annual 
report 2007. Kildare: The State 
Laboratory.
The State Laboratory (2009) 2. Annual 
report 2008. Kildare: The State 
Laboratory. 
www.statelab.ie/PDF/AnnRep2008.pdf
Anthrax outbreak in heroin users in the 
UK and Germany
Since early December 2009, public health authorities in 
Scotland have identifi ed 27 cases of anthrax in heroin users, 
of whom 10 have died. In England, there were three cases 
of anthrax among heroin users, one of whom died. In 
Germany, one heroin user died of an anthrax infection. 
Anthrax is a very rare but serious infection caused by the 
bacterium Bacillus anthracis. If the bacterium enters the 
bloodstream or the brain and is not treated early, it is usually 
fatal. Important symptoms of anthrax are marked redness 
and swelling around an injection site and/or a very high 
temperature. There have been no cases of anthrax infection 
identifi ed in Ireland.
Further information is available on the following websites:
www.hps.scot.nhs.uk/anthrax/index.aspx
www.hpa.org.uk/HPA/Topics/InfectiousDiseases/
InfectionsAZ/1191942145749/
http://ndsc.newsweaver.ie/epiinsight/1of2s8hqbmy1trn9tg
2qo4
The State Laboratory annual report 2008
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The Irish Needle Exchange Forum 
conference
The Irish Needle Exchange Forum (INEF) held its inaugural 
conference at the Malton Hotel, Killarney, Co Kerry, on 5 
November 2009. The INEF is the fi rst dedicated resource 
for those working in the fi eld of harm reduction and needle 
exchange (NX) in Ireland and is linked to the main national 
and international harm reduction organisations. The forum 
aims to provide those working in the fi eld with a platform to 
initiate open, informed discussion and debate, and to raise 
concerns and move issues forward, to identify and promote 
good practice in the development and delivery of needle 
exchange services. The INEF believes that harm reduction 
complements abstinence-based approaches by providing 
service users with the knowledge and tools to stay safe until 
they can achieve and maintain abstinence.
The INEF conference was well attended. Speakers in the 
morning session included Dr Shane Butler, who spoke 
about extending needle-exchange provision across the 
Irish healthcare system; Tony Duffi n, director of Ana Liffey, 
who discussed harm reduction within the continuum of 
care approach, and Tony Geoghan, director of Merchants 
Quay Ireland (MQI), who presented a profi le of service 
users at the needle-exchange facility in MQI. International 
speakers included Rick Lines, who presented evidence on the 
effectiveness of needle- and syringe-exchange programmes 
in prisons, and Jamie Bridges, who explored the concept 
of harm reduction; both Rick and Jamie work for the 
International Harm Reduction Association (IRHA).
The afternoon session included three workshops: needle and 
syringe provision for adolescent users; working with women 
drug users who engage in risky sexual behaviour; and blood- 
borne viruses. The workshops were very well attended and 
covered many practical issues that were relevant to front-line 
workers. The afternoon session also included presentations 
from Martin Chandler (UK), who presented on research 
that examined the risks of taking performance and image-
enhancing drugs (PIEDS), and Lloyd Belcher (UK), who 
presented on research into secondary peer needle exchange 
programmes. John Craven from the HSE East Coast Area 
Addiction Services presented a profi le of the needle 
exchange back-packing service that is delivered locally. 
Dr Denis O’Driscoll, chief pharmacist at HSE Addiction 
Services Dublin Mid-Leinster, and Mr Rory Keane, Regional 
Drug Co-ordination Unit HSE Mid-West, presented an 
overview of plans to provide additional needle exchange-
services through community pharmacies in 65 new locations 
across the country. It is envisaged that the services will be 
targeted to areas outside Dublin and the former Eastern 
Regional Health Authority. The services proposed will come 
from a new partnership between the Irish Pharmacy Union 
(IPU), the Health Service Executive (HSE) and the Elton John 
Aids Foundation (EJAF). The service will be part-funded by 
the EJAF for three years, with matching funding by the HSE. 
The HSE will take responsibility for funding in year four. 
It is envisaged that in the fi rst year a national pharmacy 
co-ordinator will be appointed and regional pharmacy 
liaison staff and participating pharmacies will be recruited. 
These actions will be supported by developing a training 
programme for participating pharmacists. Needle-exchange 
services will be provided free in pharmacies and will include 
both custom-made and standard packs. It is envisaged that 
the service will exchange new injecting equipment for old, 
provide sharps bins and advice on safe disposal of used 
equipment, information on safer-injecting and safe 
sex practices, and advice on drug use and other health-
related issues.
The INEF is chaired by Mr Tim Bingham. More information 
about the forum and its activities can be found on the 
website www.inef.ie
(Martin Keane)
2010 Directory of training courses 
The National Documentation Centre on 
Drug Use has published a new edition 
of the Directory of courses and training 
programmes on drug misuse in Ireland. 
Forty-two providers sent us information 
about 102 courses for this fi fth edition. 
We would like to thank all of those who 
made contributions. 
Most courses refer directly to drugs or addiction, though 
others aim to develop broad skills, such as supervision, 
facilitation and counselling techniques, which may be 
of interest to those working in this area. A wide variety 
of training standards, methods and approaches 
are represented. 
We do not assess the quality of courses listed; we present 
information as supplied by the course co-ordinators on 
course length, assessment, qualifi cations and accreditation. 
Course providers are based in Dublin (60%), Cork, 
Donegal, Kildare, Galway, Leitrim, Limerick, Mayo, Meath, 
Roscommon, Tipperary, Waterford and Westmeath. 
Although many cater specifi cally for people in their locality, 
some also offer courses on a regional or national basis. 
A small number of task forces offer fi nancial assistance for 
those living or working in their area to attend specifi ed 
courses. We provide information on their application criteria. 
Course co-ordinators who wish to revise an existing entry or 
include a new course in the 2011 edition of the Directory 
may request an application form from mdunne@hrb.ie 
(Mary Dunne)
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EMCDDA and Europol step up information collection 
on mephedrone
Extract from article by the Action on new drugs team printed 
in Drugnet Europe No. 69, January–March 2010 
Synthetic cathinones are increasingly being reported to 
the EMCDDA and Europol via the EU early-warning system 
(EWS). These ‘designer’ compounds, structurally related 
to amphetamine, are derivatives of the parent compound 
cathinone, one of the psychoactive ingredients found in 
khat (Catha edulis). In 2008, six of the 13 psychoactive 
substances reported via the EWS were synthetic derivatives 
of cathinone.
Some 15 synthetic cathinones are currently being 
monitored through the EWS, among these mephedrone 
(4-methylmethcathinone). Now apparently more popular 
among drug users as a ‘legal high’ — legal alternative to 
amphetamine, cocaine and ecstasy — the substance has 
recently attracted considerable media attention. To date, 
there has been one confi rmed mephedrone-related death in 
Sweden and others suspected in the UK. 
A rapid audit on the availability of mephedrone on the 
Internet at the end of 2009 showed that at least 31 websites 
were selling the substance, around three-quarters of them 
being dedicated mephedrone sites. ...
... the EMCDDA and Europol agreed to launch a formal 
procedure to collect further information on the substance. 
This will lead to the production of an EMCDDA–Europol 
Joint report to be presented to the Council of the EU, the 
European Commission and the European Medicines Agency. 
On the basis of this report, a decision can be taken on 
whether or not to launch a formal risk-assessment procedure 
on the substance. 
Health and prisons in Europe
Cited from article by Linda Montanari, Dagmar Hedrich 
and Lucas Wiessing in Drugnet Europe No. 69, 
January–March 2010
Prisoners are entitled to the same level of medical care as 
persons living in the community. Prison health services 
should therefore be able to provide treatment for drug 
problems in conditions comparable to those offered outside 
prison. This general principle of equivalence is recognised 
within the EU by a 2003 Council recommendation on the 
prevention and reduction of health-related harm associated 
with drug dependence. The current EU drugs action plan 
(2009–12) calls for its implementation. The issue of health in 
prisons was the focus of two European conferences held in 
October and November in Madrid and Oslo. 
Several issues regarding prison health and drug use were 
raised at these events, including the high proportion of drug 
users in prison, the spread of infectious diseases and the 
high risk of drug-related deaths after release from prison. 
The events resulted in specifi c recommendations covering 
topics such as the prevention of post-release mortality, 
notably via the continuation of substitution treatment in 
prison. Also stressed was the need to boost evidence-based 
treatment in prison and to strengthen the link between 
prison and public health services.
Madrid conference: The Madrid recommendation: Health 
protection in prisons as an essential part of public health, 
www.prisonhealthconference2009.com
Oslo conference: www.ndphs.org/?mtgs,prison_health_
public_health
Drugnet Europe is the quarterly newsletter of the European 
Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA). Drugs in focus is a series of policy briefi ngs 
published by the EMCDDA. Both publications are available 
at www.emcdda.europa.eu.
If you would like a hard copy of the current or future issues 
of either publication, please contact: 
Health Research Board
Knockmaun House
42–47 Lower Mount Street
Dublin 2 
Tel: 01 2345 127 
Email: drugnet@hrb.ie
From Drugnet Europe
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In brief
On 10 September 2009 the European Communities (Road 
Haulage and Road Passenger Transport Operator’s 
Licences) Regulations 2009 (SI No 318 of 2009) came 
into effect. In the Dáil on 5 November, Minister for 
Transport Noel Dempsey TD explained that this regulation 
automatically disqualifi es from holding a road transport 
operator’s licence any operator who has serious convictions 
in a number of specifi c areas, including drug-traffi cking, 
money laundering and fi rearms offences. Any licensee 
continuing to operate while disqualifi ed risks receiving a 
maximum fi ne of €500,000 or three years in prison, or both. 
www.attorneygeneral.ie 
On 4 November 2009 the Independent Monitoring 
Commission (IMC) published its 22nd report. In assessing 
current activities by republican paramilitary groups the IMC 
reported, ‘we note that a factor behind the increase in the 
number of attacks in some nationalist areas appears to have 
been the growth of vigilante organisations which claim to 
want to “clean up” (their term) anti-social behaviour. Two 
such groupings are Concerned Families Against Drugs in 
Belfast and Republican Action Against Drugs in Derry. We 
believe that both these groups have undertaken attacks, 
including the use of pipe-bombs.’ With regard to loyalist 
paramilitary groups, the IMC reported in relation to the 
Ulster Defence Association (UDA) that, ‘notwithstanding 
the efforts of some in the leadership to reduce criminality 
[including drug dealing, robbery, extortion and the supply 
of contraband cigarettes], some senior fi gures remain 
directly involved or give their personal approval.’ 
www.independentmonitoringcommission.org 
On 13 November 2009 the British–Irish Council (BIC) 
held its thirteenth Summit meeting in Jersey. The meeting 
heard that the Sectoral Group on the Misuse of Drugs had 
held three Senior Offi cial meetings in 2009. (1) In March, 
Guernsey briefed the group on the introduction of their new 
legislation to ban Spice and other psychoactive substances. 
(2) In May, Dr Suzi Lyons of the Alcohol and Drugs Research 
Unit of the Health Research Board gave a presentation to 
the group on the development and the content of Ireland’s 
National Drug-Related Deaths Index. (3) The September 
meeting focused on prevention and on how Scotland was 
raising awareness in the overall population of the dangers of 
drug use through their national Know the Score campaign. 
www.britishirishcouncil.org 
On 19 November 2009 the Defence Forces policy on drugs 
was the subject of a Parliamentary Question. Minister for 
Defence Willie O’Dea TD stated: ‘A Compulsory Random 
Drug Testing (CRDT) programme aimed at deterrence 
was introduced in October 2002. Since then, 10,178 tests 
have been conducted with 41 tests yielding a positive 
result (4.0%). To date, a total of 25 members have been 
discharged as a result of a positive test result.’ 
www.oireachtas.ie 
On 2 December 2009 the numbers employed by drugs 
task forces were the subject of a Parliamentary Question. 
Minister of State John Curran TD responded that in 2009 the 
number of people employed in the task forces and receiving 
funding from the Department’s Drugs Initiative was 34 in 
the local drugs task forces at a cost of €1.583 million, and 
20 in the regional drugs task forces at a cost of €926,000. 
The Minister noted that some of these people worked in a 
part-time or job-sharing capacity; that in some instances, 
the task forces employed the people directly, while in others 
a task force project or other local organisation acted as a 
host employer; and that the task force co-ordinators were 
employed by the HSE. www.oireachtas.ie
On 9 December 2009 the Board of the Homeless Agency 
Partnership acknowledged signifi cant advances in 
addressing homelessness in Dublin, including a decline in 
rough sleeping, implementation of a new model of homeless 
services, and localisation of homeless services across city and 
county. Cathal Morgan, director of the Homeless Agency, 
commented, ‘This decline coincides with the intensive 
collaborative working that has taken place between all 
statutory and voluntary members of the Homeless Agency 
Partnership in identifying and securing long-term tenancies 
for people who currently reside in temporary forms of 
accommodation in homeless services.’ 
www.homelessagency.ie 
On 15 December 2009 the Children’s Mental Health 
Coalition (CMHC) was launched in central Dublin. 
Comprising more than 35 organisations, the coalition will 
lobby the government on four key demands in relation to 
mental health services and the education, care and criminal 
justice systems. Its aim is to bring to life the vision as set out 
in the State’s mental health policy – A vision for change. 
www.childrensmentalhealth.ie 
On 1 January 2010 the Spanish EU Presidency commenced. 
In its programme for the fi rst six months of the year, the 
Spanish Presidency endorses the new Stockholm Programme, 
which provides the framework for EU police and customs 
co-operation, including tackling drug traffi cking, for the 
period 2010–2014. This programme replaces the Hague 
Programme, which similarly addressed the issue of drug 
traffi cking at EU level, and which expired at the end of 2009. 
www.eu2010.es/en/ 
On 25 January 2009 the Children’s Rights Alliance (CRA), 
a coalition of over 90 NGOs working to secure the rights 
and needs of children in Ireland, launched its second 
annual ‘report card’, Is the government keeping its promises 
to children? With regard to protecting children from the 
negative consequences of alcohol use, the government was 
given an ‘F’ – ‘a fail, and a signifi cant drop from last year’s 
“D’’’. The report card states that the government has failed 
to move on recommendations made by the Strategic Task 
Force on Alcohol in relation to ‘protecting children’, and 
its decision to reduce the price of alcohol in Budget 2010 
was a step that will ‘undermine children’s wellbeing’. The 
CRA called on the government to introduce a legislative ban 
to protect children from unnecessary exposure to alcohol 
marketing; the current voluntary advertising code is not 
seen as effective. www.childrensrights.ie 
(Compiled by Brigid Pike) 
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Recent publications
Journal articles
The following abstracts are cited from recently published 
articles relating to the drugs situation in Ireland.
Lifetime history of substance misuse in fi rst-
episode psychosis: Prevalence and its infl uence on 
psychopathology and onset of psychotic symptoms
Kamali M, McTigue O, Whitty P, Gervin M, Clarke M, 
Browne S, Larkin C and O’Callaghan E
Early Intervention in Psychiatry 2009; 3(3): 198–203 
www.drugsandalcohol.ie/12822/ 
Introduction and aims: Substance misuse (drug/alcohol 
dependence or abuse) in psychotic illness is an increasingly 
recognised problem. We aimed to estimate the prevalence 
and examine the infl uence of substance misuse on age at 
onset of psychosis and psychopathology among patients 
with fi rst-episode psychosis.
Method: One hundred seventy-one consecutive patients 
with fi rst-episode psychosis were assessed. Substance 
misuse, age of onset of psychosis and psychopathology were 
determined using valid instruments.
Results: Seventy-seven (46%) patients had a lifetime history 
of substance misuse and were predominately males, had 
more positive symptoms, and in the majority of cases (84%), 
started misusing substances before the onset of psychosis 
(SM-BP). There was no difference in age of onset between 
patients with SM-BP and the rest of the sample.
Conclusion: Lifetime history of substance misuse is common 
and may infl uence psychopathology, but does not appear 
to infl uence or bring forward the age at onset of 
psychotic symptoms.
The functional outcome and recovery of patients 
admitted to an intensive care unit following drug 
overdose: a follow-up study
O’Brien BP, Murphy D, Conrick-Martin I and Marsh B 
Anaesthesia and Intensive Care 2009; 37(5): 802–806 
www.drugsandalcohol.ie/12823/ 
Patients who have overdosed on drugs commonly present 
to emergency departments, with only the most severe 
cases requiring intensive care unit (ICU) admission. Such 
patients typically survive hospitalisation. We studied their 
longer term functional outcomes and recovery patterns, 
which have not been well described. All patients admitted 
to the 18-bed ICU of a university-affi liated teaching hospital 
following drug overdoses between 1 January 2004 and 31 
December 2006 were identifi ed. With ethical approval, we 
evaluated the functional outcome and recovery patterns 
of the surviving patients 31 months after presentation, by 
telephone or personal interview. These were recorded as 
Glasgow outcome score, Karnofsky performance index 
and present work status. During the three years studied, 
43 patients were identifi ed as being admitted to our ICU 
because of an overdose. The average age was 34 years, 72% 
were male and the mean APACHE II score was 16.7. Of these, 
32 were discharged from hospital alive. Follow-up data was 
attained on all of them. At a median of 31 months follow-
up, a further eight had died. Of the 24 surviving there were 
13 unemployed, seven employed and four in custody. The 
median Glasgow outcome score of survivors was 4.5, their 
Karnofsky score 80. Admission to ICU for treatment of 
overdose is associated with a very high risk of death in both 
the short and long term. While excellent functional recovery 
is achievable, 16% of survivors were held in custody and 
54% unemployed.
Empirically defi ned subtypes of alcohol dependence in 
an Irish family sample
Sintov ND, Kendler KS, Young-Wolff KC, Walsh D, Patterson 
DG and Prescott CA
Drug and Alcohol Dependence 2009; (In press) 
www.drugsandalcohol.ie/12825/ 
Alcohol dependence (AD) is clinically and etiologically 
heterogeneous. The goal of this study was to explore AD 
subtypes among a sample of 1,221 participants in the Irish 
Affected Sib Pair Study of Alcohol Dependence, all of whom 
met DSM-IV criteria for AD.
Variables used to identify the subtypes included major 
depressive disorder, antisocial personality disorder, illicit 
drug dependence (cannabis, sedatives, stimulants, cocaine, 
opioids, and hallucinogens), nicotine dependence, the 
personality traits of neuroticism and novelty seeking, and 
early alcohol use. Using latent class analysis, a 3-class 
solution was identifi ed as the most parsimonious description 
of the data.
Individuals in a mild class were least likely to have comorbid 
psychopathology, whereas a severe class had highest 
probabilities of all comorbid psychopathology. The third 
class was characterised by high probabilities of major 
depression and higher neuroticism scores, but lower 
likelihood of other comorbid disorders than seen in the 
severe class.
Overall, sibling pair resemblance for class was stronger 
within than between classes, and was greatest for siblings 
within the severe class, suggesting a stronger familial 
etiology for this class. These fi ndings are consistent with the 
affective regulation and behavioral disinhibition subtypes 
of alcoholism, and are in line with prior work suggesting 
familial infl uences on subtype etiology.
Alcohol usage and associated treatment outcomes for 
opiate users entering treatment in Ireland
Stapleton RD and Comiskey CM 
Drug and Alcohol Dependence 2010; 107(1): 56–61
www.drugsandalcohol.ie/12642/ 
Evidence has shown that frequency and quantity of drug 
usage are reduced after treatment but the effect of opioid 
addiction treatment on alcohol consumption remains 
unclear. As part of the national Research Outcome Study in 
Ireland Evaluating drug treatment effectiveness (ROSIE, see 
www.nuim.ie/rosie) comprehensive drug and alcohol data 
on 404 opiate users were collected. This study recruited and 
followed up at 1 and 3 years a prospective cohort of 404 
users entering a new treatment episode. Descriptive and 
inferential statistics were computed and logistic modelling 
was used to identify key factors effecting outcomes. The 
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cohort represented 8.2% of all new treatments. Follow-
up interview rate at 3 years was 88%. Analysis revealed 
that those who abstained from alcohol use at 3 years 
were less likely to be using heroin at 3 years than non-
abstainers. In addition, those who abstained from alcohol 
use at 3 years were also less likely to be using methadone, 
benzodiazepines and cocaine at 3 years than alcohol users. 
Outcomes for medium and heavy drinkers were found not 
to be as good as alcohol abstainers. Finally males tended 
to reduce the frequency and level of alcohol usage after 
entering treatment more than females. Results demonstrate 
to clinicians that an alcohol strategy is a key component of 
opiate treatment planning and a comprehensive and regular 
assessment of the client’s alcohol and drug use profi le is 
essential if treatment interventions are to have maximum 
impact on outcomes.
(Compiled by Louise Farragher)
Upcoming events 
(Compiled by Louise Farragher – lfarragher@hrb.ie)
April
13 April 2010
Towards multi-level co-operation against drug traffi cking in 
Europe
Venue: Renaissance Hotel, Brussels
Organised by/Contact: Centre for Parliamentary Studies
Email: bookings@publicpolicyexchange.co.uk 
www.publicpolicyexchange.co.uk/events/AD13-PPE.php
Information: Since the launch of the EU Drugs Action Plan 
for 2009–2012, hopes are high that a renewed commitment 
to address the gaps in capacity building across the EU will 
have a positive impact. This special international symposium 
provides a timely opportunity for practitioners and 
stakeholders across the EU to discuss the latest challenges 
and consider the steps needed to revitalise the triple ‘C’ 
approach of Cooperation, Collaboration and Coordination 
in the fi ght against illicit drug traffi cking through multi-level 
and cross-border approaches in Europe.
The Centre for Parliamentary Studies welcomes the 
participation of all key partners, responsible authorities and 
stakeholders. The symposium will support the exchange 
of ideas and encourage delegates to engage in thought-
provoking topical debate.
May
24–26 May 2010
2nd World Forum Against Drugs
Venue: Stockholm, Sweden
Organised by/Contact: World Federation Against Drugs 
www.wfad.se
Information: More than 600 representatives from 82 
countries attended the fi rst World Forum Against Drugs 
in Stockholm, Sweden, in September 2008. The Forum 
resulted in a Declaration that has been signed by a large 
number of organisations and individuals. The World 
Federation Against Drugs (WFAD) was formed in 2009 in 
Vienna, Austria, with a board representing all continents.
The 2010 World Forum will focus primarily on:
New research on cannabis ■
Drugs in Sub-Saharan Africa ■
Adult drug abuse and its infl uence on children ■
June
24–25 June 2010
Drugs, alcohol and criminal justice: ethics, effectiveness and 
economics of interventions
Venue: Friends House, London 
Organised by/Contact: Conference Consortium and 
supported by Drink and Drugs News and Napo
www.connectionsproject.eu/conference2010 
Information: The University of Kent is delighted to 
announce the Second European Conference of the 
Connections Project. The conference takes place at a time of 
unprecedented competition for scarce resources everywhere. 
To be able to demonstrate ‘value for money’ is critical and 
nowhere is this more so than in drug and alcohol treatment. 
Following previous conferences where we have examined 
the various treatment models and interventions available, 
this event will seek to tease out how different modalities can 
be delivered and combined to construct a comprehensive 
treatment system, offering accessible and effective options 
to those requiring help, demonstrating value for money.
The conference will look at a range of interventions and 
treatments, from harm reduction to drug free ‘recovery’. 
The premise is that no one treatment modality can deal 
effectively with the complex range of presented need. The 
task of the conference is to discuss and debate how best the 
different components can be combined most effectively.
September
22 September 2010
30th Annual EAP Conference & Learning Institute. Drugs 
and alcohol at work: health and safety implications in the 
workplace
Venue: Ashling Hotel, Parkgate Street, Dublin 8
Organised by/Contact: EAP Institute 
www.eapinstitute.com/conference.asp
Information: This conference will feature presentations 
from health and safety professionals, EAP practitioners, 
employee relations specialists and policy makers which will 
assist delegates in developing policies and procedures that 
will comply with the Safety, Health and Welfare at Work Act 
2005. The programme will also include three presentations 
on the US experience of the Drug-Free Workplace Act which 
was implemented in 1988. At the end of this conference 
those attending will be in a position to: 
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Have full knowledge of the general duties of employers  ■
and of employees to comply with Section 80 and Section 
13 of the Safety, Health and Welfare at Work Act 2005. 
Acquire information on the development of workplace  ■
drug and alcohol policies, procedures and developing 
workplace drug and alcohol case law. 
Learn how to carry out risk assessments and develop  ■
control measures for workplace drugs and alcohol.
23 September 2010
EAP post-conference training seminar: procedures for the 
collection and processing of employee drug and alcohol 
tests 
Venue: Ashling Hotel, Parkgate Street, Dublin 8
Organised by/Contact: EAP Institute 
www.eapinstitute.com/conference.asp
October
30 September – 3 October 2010
21st Annual ESSD Conference
Venue: Dubrovnik, Croatia
Organised by/Contact: ESSD: European Society for Social 
Drug Research
www.essd-research.eu/en/index.html
Information: It has been an ESSD tradition to hold a 
conference in a different European country each year, 
preferably alternating between North, South, East and West 
Europe. Twenty conferences have been held to date, in 
16 countries. The 21st conference will be held this year in 
Dubrovnik, Croatia. Further details will be posted on the 
website in due course.
December
5–7 December 2010
Thematic meeting: Policies for reducing problems associated 
with alcohol availability
Venue: Washington Marriott Wardman Park, Washington DC
Organised by/Contact: Silver Gate Group 
www.silvergategroup.com/ap15/index.htm
Information: The US federal administration has signalled a 
renewed interest in science and public health. Meanwhile, 
states and localities are facing increased demand for public 
services in the face of declining revenues. Evidence-based 
alcohol policy can reduce alcohol problems and resultant 
social costs, simultaneously generating revenue (alcohol 
excise taxes and other user fees) to promote public health 
and safety.
This 15th conference in the Alcohol Policy series will 
explore, develop, and advance public policy approaches 
to the prevention of alcohol problems in order to promote 
evidence-based strategies and to bring focus to the need for 
alcohol policy reform at all levels – local, regional, national, 
and international. Specifi c objectives are to:
Strengthen the understanding of sound, evidence-based 
public policy in preventing and reducing alcohol-related 
problems.
Illuminate policy-making processes at local, state, regional 
and national, and international levels.
Infl uence international, national, regional, state and 
local agendas to consider rational alcohol policy, with an 
emphasis on offsetting the public costs of alcohol use.
Expand the coalition of individuals, organisations and 
agencies committed to public policy approaches to the 
prevention of alcohol problems.
Promote public discussion on specifi c alcohol policy issues, 
including sales, service, products, marketing, and other 
conditions of availability.
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